Ras family small GTPase-mediated neuroprotective signaling in stroke

Central Nervous System Agents in Medicinal Chemistry

Volumn 11, Issue 2, 2011, Pages 114-137

  Shi, Geng Xian ^a   Andres, Douglas A ^a   Cai, Weikang ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Cell death; Cell survival; Ischemia; Neuroprotection; Ras family GTPases; Signal transduction; Stroke; Transcription factors

Indexed keywords

(1,3 BENZOTHIAZOL 2 YL)[2 [2 (3 PYRIDINYL)ETHYLAMINO] 4 PYRIMIDINYL]ACETONITRILE; 1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; 4 [4 (4 FLUOROPHENYL) 5 (2 METHOXY 4 PYRIMIDINYL) 1 IMIDAZOLYL]CYCLOHEXANOL; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; CALCIUM; CASPASE 3; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; FORKHEAD TRANSCRIPTION FACTOR; GUANOSINE TRIPHOSPHATASE; HYPOXIA INDUCIBLE FACTOR 1; MAMMALIAN TARGET OF RAPAMYCIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN KINASE B; RAS ASSOCIATION DOMAIN FAMILY PROTEIN 1A; S ALLYLCYSTEINE; STRESS ACTIVATED PROTEIN KINASE; VASCULOTROPIN;

APOPTOSIS; ARTICLE; BRAIN ISCHEMIA; BRAIN REGION; CALCIUM TRANSPORT; CELL DEATH; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL REGENERATION; CELL SURVIVAL; DRUG EFFECT; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME INHIBITION; MIDDLE CEREBRAL ARTERY OCCLUSION; NERVE CELL; NEUROPROTECTION; NONHUMAN; PATHOGENESIS; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; STROKE;

EID: 79959311956     PISSN: 18715249     EISSN: 18756166     Source Type: Journal    
DOI: 10.2174/187152411796011349     Document Type: Article

References (376)

1. Lo, E. H.; Dalkara, T.; Moskowitz, M. A., Mechanisms, challenges and opportunities in stroke. Nat. Rev. Neurosci., 2003, 4 (5), 399-415.
2. Mehta, S. L.; Manhas, N.; Raghubir, R., Molecular targets in cerebral ischemia for developing novel therapeutics. Brain Res. Rev., 2007, 54 (1), 34-66.
3. Nakka, V. P.; Gusain, A.; Mehta, S. L.; Raghubir, R., Molecular mechanisms of apoptosis in cerebral ischemia: multiple neuroprotective opportunities. Mol. Neurobiol., 2008, 37 (1), 7-38.
4. Rogalewski, A.; Schneider, A.; Ringelstein, E. B.; Schabitz, W. R., Toward a multimodal neuroprotective treatment of stroke. Stroke, 2006, 37 (4), 1129-1136.
5. Ogawa, S.; Kitao, Y.; Hori, O., Ischemia-induced neuronal cell death and stress response. Antioxid. Redox Signal., 2007, 9 (5), 573-587.
6. Bredesen, D. E.; Rao, R. V.; Mehlen, P., Cell death in the nervous system. Nature, 2006, 443 (7113), 796-802.
7. Adhami, F.; Schloemer, A.; Kuan, C. Y., The roles of autophagy in cerebral ischemia. Autophagy, 2007, 3 (1), 42-44.
8. Adhami, F.; Liao, G.; Morozov, Y. M.; Schloemer, A.; Schmithorst, V. J.; Lorenz, J. N.; Dunn, R. S.; Vorhees, C. V.; Wills-Karp, M.; Degen, J. L.; Davis, R. J.; Mizushima, N.; Rakic, P.; Dardzinski, B. J.; Holland, S. K.; Sharp, F. R.; Kuan, C. Y., Cerebral ischemia-hypoxia induces intravascular coagulation and autophagy. Am. J. Pathol., 2006, 169 (2), 566-583.
9. Hardingham, G. E.; Bading, H., The Yin and Yang of NMDA receptor signalling. Trends Neurosci., 2003, 26 (2), 81-89.
10. [Medina, I., Extrasynaptic NMDA receptors reshape gene ranks. Sci. STKE, 2007, 2007 (386), pe23.
11. Papadia, S.; Hardingham, G. E., The dichotomy of NMDA receptor signaling. Neuroscientist, 2007, 13 (6), 572-579.
12. Hardingham, G. E., Coupling of the NMDA receptor to neuroprotective and neurodestructive events. Biochem. Soc. Trans., 2009, 37 (Pt 6), 1147-1160.
13. Lin, M. T.; Beal, M. F., Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature, 2006, 443 (7113), 787-795.
14. Hara, M. R.; Snyder, S. H., Cell signaling and neuronal death. Annu. Rev. Pharmacol. Toxicol., 2007, 47, 117-141.
15. Yuan, J.; Yankner, B. A., Apoptosis in the nervous system. Nature, 2000, 407 (6805), 802-809.
16. Moskowitz, M. A.; Lo, E. H., Neurogenesis and apoptotic cell death. Stroke, 2003, 34 (2), 324-326.
17. Reichardt, L. F., Neurotrophin-regulated signalling pathways. Philos. Trans. R. Soc. Lond. B. Biol. Sci., 2006, 361 (1473), 1545-1564.
18. Bourgault, S.; Vaudry, D.; Dejda, A.; Doan, N. D.; Vaudry, H.; Fournier, A., Pituitary adenylate cyclase-activating polypeptide: focus on structure-activity relationships of a neuroprotective Peptide. Curr. Med. Chem., 2009, 16 (33), 4462-4480.
19. Ohtaki, H.; Nakamachi, T.; Dohi, K.; Shioda, S., Role of PACAP in ischemic neural death. J. Mol. Neurosci., 2008, 36 (1-3), 16-25.
20. Gidday, J. M., Cerebral preconditioning and ischaemic tolerance. Nat. Rev. Neurosci., 2006, 7 (6), 437-448.
21. [Singhal, A. B.; Lo, E. H.; Dalkara, T.; Moskowitz, M. A., Advances in stroke neuroprotection: hyperoxia and beyond. Neuroimaging Clin. N. Am., 2005, 15 (3), 697-720, xii-xiii.
22. Ginsberg, M. D., Neuroprotection for ischemic stroke: past, present and future. Neuropharmacology, 2008, 55 (3), 363-389.
23. [Colicelli, J., Human RAS superfamily proteins and related GTPases. Sci. STKE, 2004, 2004 (250), RE13.
24. Skaper, S. D., The biology of neurotrophins, signalling pathways, and functional peptide mimetics of neurotrophins and their receptors. CNS Neurol. Disord. Drug Targets, 2008, 7 (1), 46-62.
25. Frebel, K.; Wiese, S., Signalling molecules essential for neuronal survival and differentiation. Biochem. Soc. Trans., 2006, 34 (Pt 6), 1287-1290.
26. Malumbres, M.; Barbacid, M., RAS oncogenes: the first 30 years. Nat. Rev. Cancer, 2003, 3 (6), 459-465.
27. Groves, J. T.; Kuriyan, J., Molecular mechanisms in signal transduction at the membrane. Nat. Struct. Mol. Biol., 2010, 17 (6), 659-665.
28. Plowman, S. J.; Hancock, J. F., Ras signaling from plasma membrane and endomembrane microdomains. Biochim. Biophys. Acta, 2005, 1746 (3), 274-283.
29. Hancock, J. F.; Parton, R. G., Ras plasma membrane signalling platforms. Biochem. J., 2005, 389 (Pt 1), 1-11.
30. Bernards, A.; Settleman, J., GAPs in growth factor signalling. Growth Factors, 2005, 23 (2), 143-149.
31. McKay, M. M.; Morrison, D. K., Integrating signals from RTKs to ERK/MAPK. Oncogene, 2007, 26 (22), 3113-3121.
32. Huang, E. J.; Reichardt, L. F., Trk receptors: roles in neuronal signal transduction. Annu. Rev. Biochem., 2003, 72, 609-642.
33. [Jeanneteau, F.; Chao, M. V., Promoting neurotrophic effects by GPCR ligands. Novartis Found. Symp., 2006, 276, 181-189; discussion 189-192, 233-187, 275-181.
34. [Gerdin, M. J.; Eiden, L. E., Regulation of PC12 cell differentiation by cAMP signaling to ERK independent of PKA: do all the connections add up? Sci. STKE, 2007, 2007 (382), pe15.
35. Kholodenko, B. N.; Hancock, J. F.; Kolch, W., Signalling ballet in space and time. Nat. Rev. Mol. Cell. Biol., 2010, 11 (6), 414-426.
36. Hancock, J. F., Ras proteins: different signals from different locations. Nat. Rev. Mol. Cell. Biol., 2003, 4 (5), 373-384.
37. Shi, G. X.; Andres, D. A., Rit contributes to nerve growth factorinduced neuronal differentiation via activation of B-Rafextracellular signal-regulated kinase and p38 mitogen-activated protein kinase cascades. Mol. Cell. Biol., 2005, 25 (2), 830-846.
38. Shi, G. X.; Rehmann, H.; Andres, D. A., A novel cyclic AMPdependent Epac-Rit signaling pathway contributes to PACAP38- mediated neuronal differentiation. Mol. Cell. Biol., 2006, 26 (23), 9136-9147.
39. Shao, H.; Andres, D. A., A novel RalGEF-like protein, RGL3, as a candidate effector for rit and Ras. J. Biol. Chem., 2000, 275 (35), 26914-26924.
40. Shao, H.; Kadono-Okuda, K.; Finlin, B. S.; Andres, D. A., Biochemical characterization of the Ras-related GTPases Rit and Rin. Arch. Biochem. Biophys., 1999, 371 (2), 207-219.
41. Shi, G. X.; Jin, L.; Andres, D. A., Src-dependent TrkA transactivation is required for pituitary adenylate cyclase-activating polypeptide 38-mediated Rit activation and neuronal differentiation. Mol. Biol. Cell, 2010, 21 (9), 1597-1608.
42. Spencer, M. L.; Shao, H.; Andres, D. A., Induction of neurite extension and survival in pheochromocytoma cells by the Rit GTPase. J. Biol. Chem., 2002, 277 (23), 20160-20168.
43. Hynds, D. L.; Spencer, M. L.; Andres, D. A.; Snow, D. M., Rit promotes MEK-independent neurite branching in human neuroblastoma cells. J. Cell Sci., 2003, 116 (Pt 10), 1925-1935.
44. Hoshino, M.; Yoshimori, T.; Nakamura, S., Small GTPase proteins Rin and Rit Bind to PAR6 GTP-dependently and regulate cell transformation. J. Biol. Chem., 2005, 280 (24), 22868-22874.
45. Lein, P. J.; Guo, X.; Shi, G. X.; Moholt-Siebert, M.; Bruun, D.; Andres, D. A., The novel GTPase Rit differentially regulates axonal and dendritic growth. J. Neurosci., 2007, 27 (17), 4725-4736.
46. Andres, D. A.; Shi, G. X.; Bruun, D.; Barnhart, C.; Lein, P. J., Rit signaling contributes to interferon-gamma-induced dendritic retraction via p38 mitogen-activated protein kinase activation. J. Neurochem., 2008, 107 (5), 1436-1447.
47. Shi, G. X.; Han, J.; Andres, D. A., Rin GTPase couples nerve growth factor signaling to p38 and b-Raf/ERK pathways to promote neuronal differentiation. J. Biol. Chem., 2005, 280 (45), 37599-37609.
48. Shi, G. X.; Jin, L.; Andres, D. A., Pituitary adenylate cyclaseactivating polypeptide 38-mediated Rin activation requires Src and contributes to the regulation of HSP27 signaling during neuronal differentiation. Mol. Cell. Biol., 2008, 28 (16), 4940-4951.
49. Spencer, M. L.; Shao, H.; Tucker, H. M.; Andres, D. A., Nerve growth factor-dependent activation of the small GTPase Rin. J. Biol. Chem., 2002, 277 (20), 17605-17615.
50. Hoshino, M.; Nakamura, S., The Ras-like small GTP-binding protein Rin is activated by growth factor stimulation. Biochem. Biophys. Res. Commun., 2002, 295 (3), 651-656.
51. Lopez De Jesus, M.; Stope, M. B.; Oude Weernink, P. A.; Mahlke, Y.; Borgermann, C.; Ananaba, V. N.; Rimmbach, C.; Rosskopf, D.; Michel, M. C.; Jakobs, K. H.; Schmidt, M., Cyclic AMP-dependent and Epac-mediated activation of R-Ras by G protein-coupled receptors leads to phospholipase D stimulation. J. Biol. Chem., 2006, 281 (31), 21837-21847.
52. Keiper, M.; Stope, M. B.; Szatkowski, D.; Bohm, A.; Tysack, K.; Vom Dorp, F.; Saur, O.; Oude Weernink, P. A.; Evellin, S.; Jakobs, K. H.; Schmidt, M., Epac- and Ca2+ -controlled activation of Ras and extracellular signal-regulated kinases by Gs-coupled receptors. J. Biol. Chem., 2004, 279 (45), 46497-46508.
53. Tian, X.; Gotoh, T.; Tsuji, K.; Lo, E. H.; Huang, S.; Feig, L. A., Developmentally regulated role for Ras-GRFs in coupling NMDA glutamate receptors to Ras, Erk and CREB. Embo J., 2004, 23 (7), 1567-1575.
54. Zhu, Y.; Pak, D.; Qin, Y.; McCormack, S. G.; Kim, M. J.; Baumgart, J. P.; Velamoor, V.; Auberson, Y. P.; Osten, P.; van Aelst, L.; Sheng, M.; Zhu, J. J., Rap2-JNK removes synaptic AMPA receptors during depotentiation. Neuron, 2005, 46 (6), 905-916.
55. Gonzalez-Zulueta, M.; Feldman, A. B.; Klesse, L. J.; Kalb, R. G.; Dillman, J. F.; Parada, L. F.; Dawson, T. M.; Dawson, V. L., Requirement for nitric oxide activation of p21(ras)/extracellular regulated kinase in neuronal ischemic preconditioning. Proc. Natl. Acad. Sci. USA, 2000, 97 (1), 436-441.
56. Yun, H. Y.; Gonzalez-Zulueta, M.; Dawson, V. L.; Dawson, T. M., Nitric oxide mediates N-methyl-D-aspartate receptor-induced activation of p21ras. Proc. Natl. Acad. Sci. USA, 1998, 95 (10), 5773-5778.
57. Wainwright, M. S.; Brennan, L. A.; Dizon, M. L.; Black, S. M., p21ras activation following hypoxia-ischemia in the newborn rat brain is dependent on nitric oxide synthase activity but p21ras does not contribute to neurologic injury. Brain Res. Dev. Brain Res., 2003, 146 (1-2), 79-85.
58. Li, S.; Tian, X.; Hartley, D. M.; Feig, L. A., Distinct roles for Rasguanine nucleotide-releasing factor 1 (Ras-GRF1) and Ras-GRF2 in the induction of long-term potentiation and long-term depression. J. Neurosci., 2006, 26 (6), 1721-1729.
59. Kim, M. J.; Dunah, A. W.; Wang, Y. T.; Sheng, M., Differential roles of NR2A- and NR2B-containing NMDA receptors in Ras- ERK signaling and AMPA receptor trafficking. Neuron, 2005, 46 (5), 745-760.
60. Arai, J. A.; Li, S.; Feig, L. A., Sos2 is dispensable for NMDAinduced Erk activation and LTP induction. Neurosci. Lett., 2009, 455 (1), 22-25.
61. Kim, J. H.; Liao, D.; Lau, L. F.; Huganir, R. L., SynGAP: a synaptic RasGAP that associates with the PSD-95/SAP90 protein family. Neuron, 1998, 20 (4), 683-691.
62. Pena, V.; Hothorn, M.; Eberth, A.; Kaschau, N.; Parret, A.; Gremer, L.; Bonneau, F.; Ahmadian, M. R.; Scheffzek, K., The C2 domain of SynGAP is essential for stimulation of the Rap GTPase reaction. EMBO Rep., 2008, 9 (4), 350-355.
63. Wu, L. X.; Sun, C. K.; Zhang, Y. M.; Fan, M.; Xu, J.; Ma, H.; Zhang, J., Involvement of the Snk-SPAR pathway in glutamateinduced excitotoxicity in cultured hippocampal neurons. Brain Res., 2007, 1168, 38-45.
64. Pak, D. T.; Yang, S.; Rudolph-Correia, S.; Kim, E.; Sheng, M., Regulation of dendritic spine morphology by SPAR, a PSD-95- associated RapGAP. Neuron, 2001, 31 (2), 289-303.
65. Roy, B. C.; Kohu, K.; Matsuura, K.; Yanai, H.; Akiyama, T., SPAL, a Rap-specific GTPase activating protein, is present in the NMDA receptor-PSD-95 complex in the hippocampus. Genes Cells, 2002, 7 (6), 607-617.
66. Song, B.; Meng, F.; Yan, X.; Guo, J.; Zhang, G., Cerebral ischemia immediately increases serine phosphorylation of the synaptic RASGTPase activating protein SynGAP by calcium/calmodulindependent protein kinase II alpha in hippocampus of rats. Neurosci. Lett., 2003, 349 (3), 183-186.
67. Song, B.; Yan, X. B.; Zhang, G. Y., PSD-95 promotes CaMKIIcatalyzed serine phosphorylation of the synaptic RAS-GTPase activating protein SynGAP after transient brain ischemia in rat hippocampus. Brain Res., 2004, 1005 (1-2), 44-50.
68. Chen, H. J.; Rojas-Soto, M.; Oguni, A.; Kennedy, M. B., A synaptic Ras-GTPase activating protein (p135 SynGAP) inhibited by CaM kinase II. Neuron, 1998, 20 (5), 895-904.
69. Komiyama, N. H.; Watabe, A. M.; Carlisle, H. J.; Porter, K.; Charlesworth, P.; Monti, J.; Strathdee, D. J.; O'Carroll, C. M.; Martin, S. J.; Morris, R. G.; O'Dell, T. J.; Grant, S. G., SynGAP regulates ERK/MAPK signaling, synaptic plasticity, and learning in the complex with postsynaptic density 95 and NMDA receptor. J. Neurosci., 2002, 22 (22), 9721-9732.
70. Krapivinsky, G.; Medina, I.; Krapivinsky, L.; Gapon, S.; Clapham, D. E., SynGAP-MUPP1-CaMKII synaptic complexes regulate p38 MAP kinase activity and NMDA receptor-dependent synaptic AMPA receptor potentiation. Neuron, 2004, 43 (4), 563-574.
71. Pei, L.; Teves, R. L.; Wallace, M. C.; Gurd, J. W., Transient cerebral ischemia increases tyrosine phosphorylation of the synaptic RAS-GTPase activating protein, SynGAP. J. Cereb. Blood Flow Metab., 2001, 21 (8), 955-963.
72. Oh, J. S.; Manzerra, P.; Kennedy, M. B., Regulation of the neuronspecific Ras GTPase-activating protein, synGAP, by Ca2+/calmodulin-dependent protein kinase II. J. Biol. Chem., 2004, 279 (17), 17980-17988.
73. Kim, J. H.; Lee, H. K.; Takamiya, K.; Huganir, R. L., The role of synaptic GTPase-activating protein in neuronal development and synaptic plasticity. J. Neurosci., 2003, 23 (4), 1119-1124.
74. Knuesel, I.; Elliott, A.; Chen, H. J.; Mansuy, I. M.; Kennedy, M. B., A role for synGAP in regulating neuronal apoptosis. Eur. J. Neurosci., 2005, 21 (3), 611-621.
75. Muhia, M.; Yee, B. K.; Feldon, J.; Markopoulos, F.; Knuesel, I., Disruption of hippocampus-regulated behavioural and cognitive processes by heterozygous constitutive deletion of SynGAP. Eur. J. Neurosci., 2010, 31(3), 529-543.
76. Guo, X.; Hamilton, P. J.; Reish, N. J.; Sweatt, J. D.; Miller, C. A.; Rumbaugh, G., Reduced expression of the NMDA receptorinteracting protein SynGAP causes behavioral abnormalities that model symptoms of Schizophrenia. Neuropsychopharmacology, 2009, 34 (7), 1659-1672.
77. Muhia, M.; Feldon, J.; Knuesel, I.; Yee, B. K., Appetitively motivated instrumental learning in SynGAP heterozygous knockout mice. Behav. Neurosci., 2009, 123 (5), 1114-1128.
78. Hetman, M.; Kharebava, G., Survival signaling pathways activated by NMDA receptors. Curr. Top. Med. Chem., 2006, 6 (8), 787-799.
79. Takeda, K.; Ichijo, H., Neuronal p38 MAPK signalling: an emerging regulator of cell fate and function in the nervous system. Genes Cells, 2002, 7 (11), 1099-1111.
80. Kalb, R., The protean actions of neurotrophins and their receptors on the life and death of neurons. Trends Neurosci., 2005, 28 (1), 5-11.
81. Nozaki, K.; Nishimura, M.; Hashimoto, N., Mitogen-activated protein kinases and cerebral ischemia. Mol. Neurobiol., 2001, 23 (1), 1-19.
82. Sawe, N.; Steinberg, G.; Zhao, H., Dual roles of the MAPK/ERK1/2 cell signaling pathway after stroke. J. Neurosci. Res., 2008, 86 (8), 1659-1669.
83. Bassi, R.; Heads, R.; Marber, M. S.; Clark, J. E., Targeting p38- MAPK in the ischaemic heart: kill or cure? Curr. Opin. Pharmacol., 2008, 8 (2), 141-146.
84. Steenbergen, C., The role of p38 mitogen-activated protein kinase in myocardial ischemia/reperfusion injury; relationship to ischemic preconditioning. Basic Res. Cardiol., 2002, 97 (4), 276-285.
85. Philpott, K. L.; Facci, L., MAP kinase pathways in neuronal cell death. CNS Neurol. Disord. Drug Targets, 2008, 7 (1), 83-97.
86. Bonny, C.; Borsello, T.; Zine, A., Targeting the JNK pathway as a therapeutic protective strategy for nervous system diseases. Rev. Neurosci., 2005, 16 (1), 57-67.
87. Grewal, S. S.; York, R. D.; Stork, P. J., Extracellular-signalregulated kinase signalling in neurons. Curr. Opin. Neurobiol., 1999, 9 (5), 544-553.
88. Ohtsuka, T.; Shimizu, K.; Yamamori, B.; Kuroda, S.; Takai, Y., Activation of brain B-Raf protein kinase by Rap1B small GTPbinding protein. J. Biol. Chem., 1996, 271 (3), 1258-1261.
89. York, R. D.; Yao, H.; Dillon, T.; Ellig, C. L.; Eckert, S. P.; McCleskey, E. W.; Stork, P. J., Rap1 mediates sustained MAP kinase activation induced by nerve growth factor. Nature, 1998, 392 (6676), 622-626.
90. Galabova-Kovacs, G.; Kolbus, A.; Matzen, D.; Meissl, K.; Piazzolla, D.; Rubiolo, C.; Steinitz, K.; Baccarini, M., ERK and beyond: insights from B-Raf and Raf-1 conditional knockouts. Cell Cycle, 2006, 5 (14), 1514-1518.
91. Ferrer, I.; Friguls, B.; Dalfo, E.; Planas, A. M., Early modifications in the expression of mitogen-activated protein kinase (MAPK/ERK), stress-activated kinases SAPK/JNK and p38, and their phosphorylated substrates following focal cerebral ischemia. Acta Neuropathol., 2003, 105 (5), 425-437.
92. Irving, E. A.; Barone, F. C.; Reith, A. D.; Hadingham, S. J.; Parsons, A. A., Differential activation of MAPK/ERK and p38/SAPK in neurones and glia following focal cerebral ischaemia in the rat. Brain Res. Mol. Brain Res., 2000, 77 (1), 65-75.
93. Zablocka, B.; Dluzniewska, J.; Zajac, H.; Domanska-Janik, K., Opposite reaction of ERK and JNK in ischemia vulnerable and resistant regions of hippocampus: involvement of mitochondria. Brain Res. Mol. Brain Res., 2003, 110 (2), 245-252.
94. Skaper, S. D.; Facci, L.; Strijbos, P. J., Neuronal protein kinase signaling cascades and excitotoxic cell death. Ann. N. Y. Acad. Sci., 2001, 939, 11-22.
95. Cullen, P. J.; Lockyer, P. J., Integration of calcium and Ras signalling. Nat. Rev. Mol. Cell. Biol., 2002, 3 (5), 339-348.
96. Guo, J.; Wu, H. W.; Hu, G.; Han, X.; De, W.; Sun, Y. J., Sustained activation of Src-family tyrosine kinases by ischemia: a potential mechanism mediating extracellular signal-regulated kinase cascades in hippocampal dentate gyrus. Neuroscience, 2006, 143 (3), 827-836.
97. Tian, H. P.; Huang, B. S.; Zhao, J.; Hu, X. H.; Guo, J.; Li, L. X., Non-receptor tyrosine kinase Src is required for ischemiastimulated neuronal cell proliferation via Raf/ERK/CREB activation in the dentate gyrus. BMC Neurosci., 2009, 10, 139.
98. Zhao, J.; Wu, H. W.; Chen, Y. J.; Tian, H. P.; Li, L. X.; Han, X.; Guo, J., Protein phosphatase 2A-negative regulation of the protective signaling pathway of Ca2+/CaM-dependent ERK activation in cerebral ischemia. J. Neurosci. Res., 2008, 86 (12), 2733-2745.
99. Wu, H.; Li, H.; Guo, J., Spry2-mediated inhibition of the Ras/ERK pathway through interaction with Src kinase following cerebral ischemia. Brain Inj., 2008, 22 (3), 275-281.
100. Wu, H. W.; Li, H. F.; Guo, J., N-methyl-D-aspartate receptors mediate diphosphorylation of extracellular signal-regulated kinases through Src family tyrosine kinases and Ca2+/calmodulindependent protein kinase II in rat hippocampus after cerebral ischemia. Neurosci. Bull., 2007, 23 (2), 107-112.
101. Wu, H. W.; Li, H. F.; Wu, X. Y.; Zhao, J.; Guo, J., Reactive oxygen species mediate ERK activation through different Raf-1- dependent signaling pathways following cerebral ischemia. Neurosci. Lett., 2008, 432 (2), 83-87.
102. Krapivinsky, G.; Krapivinsky, L.; Manasian, Y.; Ivanov, A.; Tyzio, R.; Pellegrino, C.; Ben-Ari, Y.; Clapham, D. E.; Medina, I., The NMDA receptor is coupled to the ERK pathway by a direct interaction between NR2B and RasGRF1. Neuron, 2003, 40 (4), 775-784.
103. Salter, M. W.; Kalia, L. V., Src kinases: a hub for NMDA receptor regulation. Nat. Rev. Neurosci., 2004, 5 (4), 317-328.
104. Kalia, L. V.; Gingrich, J. R.; Salter, M. W., Src in synaptic transmission and plasticity. Oncogene, 2004, 23 (48), 8007-8016.
105. Delcourt, N.; Thouvenot, E.; Chanrion, B.; Galeotti, N.; Jouin, P.; Bockaert, J.; Marin, P., PACAP type I receptor transactivation is essential for IGF-1 receptor signalling and antiapoptotic activity in neurons. Embo J., 2007, 26 (6), 1542-1551.
106. Lee, F. S.; Chao, M. V., Activation of Trk neurotrophin receptors in the absence of neurotrophins. Proc. Natl. Acad. Sci. USA, 2001, 98 (6), 3555-3560.
107. Mojsilovic-Petrovic, J.; Jeong, G. B.; Crocker, A.; Arneja, A.; David, S.; Russell, D. S.; Kalb, R. G., Protecting motor neurons from toxic insult by antagonism of adenosine A2a and Trk receptors. J. Neurosci., 2006, 26 (36), 9250-9263.
108. Rajagopal, R.; Chao, M. V., A role for Fyn in Trk receptor transactivation by G-protein-coupled receptor signaling. Mol. Cell. Neurosci., 2006, 33 (1), 36-46.
109. Lee, F. S.; Rajagopal, R.; Kim, A. H.; Chang, P. C.; Chao, M. V., Activation of Trk neurotrophin receptor signaling by pituitary adenylate cyclase-activating polypeptides. J. Biol. Chem., 2002, 277 (11), 9096-9102.
110. Meng, D.; Shi, X.; Jiang, B. H.; Fang, J., Insulin-like growth factor-I (IGF-I) induces epidermal growth factor receptor transactivation and cell proliferation through reactive oxygen species. Free Radic. Biol. Med., 2007, 42 (11), 1651-1660.
111. Maddahi, A.; Edvinsson, L., Cerebral ischemia induces microvascular pro-inflammatory cytokine expression via the MEK/ERK pathway. J. Neuroinflammation, 2010, 7, 14.
112. Maddahi, A.; Ansar, S.; Chen, Q.; Edvinsson, L., Blockade of the MEK/ERK pathway with a raf inhibitor prevents activation of proinflammatory mediators in cerebral arteries and reduction in cerebral blood flow after subarachnoid hemorrhage in a rat model. J. Cereb. Blood Flow Metab., 2011, 31 (1), 144-154.
113. Maddahi, A.; Chen, Q.; Edvinsson, L., Enhanced cerebrovascular expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 via the MEK/ERK pathway during cerebral ischemia in the rat. BMC Neurosci., 2009, 10, 56.
114. Wang, Z. Q.; Wu, D. C.; Huang, F. P.; Yang, G. Y., Inhibition of MEK/ERK 1/2 pathway reduces pro-inflammatory cytokine interleukin-1 expression in focal cerebral ischemia. Brain Res., 2004, 996 (1), 55-66.
115. Alessandrini, A.; Namura, S.; Moskowitz, M. A.; Bonventre, J. V., MEK1 protein kinase inhibition protects against damage resulting from focal cerebral ischemia. Proc. Natl. Acad. Sci. USA, 1999, 96 (22), 12866-12869.
116. Namura, S.; Iihara, K.; Takami, S.; Nagata, I.; Kikuchi, H.; Matsushita, K.; Moskowitz, M. A.; Bonventre, J. V.; Alessandrini, A., Intravenous administration of MEK inhibitor U0126 affords brain protection against forebrain ischemia and focal cerebral ischemia. Proc. Natl. Acad. Sci. USA, 2001, 98 (20), 11569-11574.
117. Wang, X.; Wang, H.; Xu, L.; Rozanski, D. J.; Sugawara, T.; Chan, P. H.; Trzaskos, J. M.; Feuerstein, G. Z., Significant neuroprotection against ischemic brain injury by inhibition of the MEK1 protein kinase in mice: exploration of potential mechanism associated with apoptosis. J. Pharmacol. Exp. Ther., 2003, 304 (1), 172-178.
118. Kim, J. M.; Lee, J. C.; Chang, N.; Chun, H. S.; Kim, W. K., SAllyl- L-cysteine attenuates cerebral ischemic injury by scavenging peroxynitrite and inhibiting the activity of extracellular signalregulated kinase. Free Radic. Res., 2006, 40 (8), 827-835.
119. Xu, X.; Chua, C. C.; Gao, J.; Hamdy, R. C.; Chua, B. H., Humanin is a novel neuroprotective agent against stroke. Stroke, 2006, 37 (10), 2613-2619.
120. Yu, C. G.; Yezierski, R. P.; Joshi, A.; Raza, K.; Li, Y.; Geddes, J. W., Involvement of ERK2 in traumatic spinal cord injury. J. Neurochem., 2010, 113(1), 131-142.
121. Gu, Z.; Jiang, Q.; Zhang, G., Extracellular signal-regulated kinase 1/2 activation in hippocampus after cerebral ischemia may not interfere with postischemic cell death. Brain Res., 2001, 901 (1-2), 79-84.
122. Gu, Z.; Jiang, Q.; Zhang, G., Extracellular signal-regulated kinase and c-Jun N-terminal protein kinase in ischemic tolerance. Neuroreport, 2001, 12 (16), 3487-3491.
123. Gu, Z.; Jiang, Q.; Zhang, G.; Cui, Z.; Zhu, Z., Diphosphorylation of extracellular signal-regulated kinases and c-Jun N-terminal protein kinases in brain ischemic tolerance in rat. Brain Res., 2000, 860 (1-2), 157-160.
124. Endres, M.; Fan, G.; Hirt, L.; Fujii, M.; Matsushita, K.; Liu, X.; Jaenisch, R.; Moskowitz, M. A., Ischemic brain damage in mice after selectively modifying BDNF or NT4 gene expression. J. Cereb. Blood Flow Metab., 2000, 20 (1), 139-144.
125. Ferrer, I.; Ballabriga, J.; Marti, E.; Perez, E.; Alberch, J.; Arenas, E., BDNF up-regulates TrkB protein and prevents the death of CA1 neurons following transient forebrain ischemia. Brain Pathol., 1998, 8 (2), 253-261.
126. Ferrer, I.; Krupinski, J.; Goutan, E.; Marti, E.; Ambrosio, S.; Arenas, E., Brain-derived neurotrophic factor reduces cortical cell death by ischemia after middle cerebral artery occlusion in the rat. Acta Neuropathol., 2001, 101 (3), 229-238.
127. Salazar-Colocho, P.; Del Rio, J.; Frechilla, D., Serotonin 5-hT1A receptor activation prevents phosphorylation of NMDA receptor NR1 subunit in cerebral ischemia. J. Physiol. Biochem., 2007, 63 (3), 203-211.
128. Salazar-Colocho, P.; Del Rio, J.; Frechilla, D., Neuroprotective effects of serotonin 5-HT 1A receptor activation against ischemic cell damage in gerbil hippocampus: Involvement of NMDA receptor NR1 subunit and BDNF. Brain Res., 2008, 1199, 159-166.
129. Kharebava, G.; Makonchuk, D.; Kalita, K. B.; Zheng, J. J.; Hetman, M., Requirement of 3-phosphoinositide-dependent protein kinase-1 for BDNF-mediated neuronal survival. J. Neurosci., 2008, 28 (44), 11409-11420.
130. McKay, M. M.; Ritt, D. A.; Morrison, D. K., Signaling dynamics of the KSR1 scaffold complex. Proc. Natl. Acad. Sci. USA, 2009, 106 (27), 11022-11027.
131. Szatmari, E.; Kalita, K. B.; Kharebava, G.; Hetman, M., Role of kinase suppressor of Ras-1 in neuronal survival signaling by extracellular signal-regulated kinase 1/2. J. Neurosci., 2007, 27 (42), 11389-11400.
132. Koh, P. O., Melatonin attenuates the cerebral ischemic injury via the MEK/ERK/p90RSK/bad signaling cascade. J. Vet. Med. Sci., 2008, 70 (11), 1219-1223.
133. Kilic, E.; Kilic, U.; Soliz, J.; Bassetti, C. L.; Gassmann, M.; Hermann, D. M., Brain-derived erythropoietin protects from focal cerebral ischemia by dual activation of ERK-1/-2 and Akt pathways. Faseb J., 2005, 19 (14), 2026-2028.
134. [Boscia, F.; Esposito, C. L.; Di Crisci, A.; de Franciscis, V.; Annunziato, L.; Cerchia, L., GDNF selectively induces microglial activation and neuronal survival in CA1/CA3 hippocampal regions exposed to NMDA insult through Ret/ERK signalling. PLoS One, 2009, 4 (8), e6486.
135. Stumm, R.; Kolodziej, A.; Prinz, V.; Endres, M.; Wu, D. F.; Hollt, V., Pituitary adenylate cyclase-activating polypeptide is upregulated in cortical pyramidal cells after focal ischemia and protects neurons from mild hypoxic/ischemic damage. J. Neurochem., 2007, 103 (4), 1666-1681.
136. Falluel-Morel, A.; Aubert, N.; Vaudry, D.; Basille, M.; Fontaine, M.; Fournier, A.; Vaudry, H.; Gonzalez, B. J., Opposite regulation of the mitochondrial apoptotic pathway by C2-ceramide and PACAP through a MAP-kinase-dependent mechanism in cerebellar granule cells. J. Neurochem., 2004, 91 (5), 1231-1243.
137. Ohtaki, H.; Nakamachi, T.; Dohi, K.; Aizawa, Y.; Takaki, A.; Hodoyama, K.; Yofu, S.; Hashimoto, H.; Shintani, N.; Baba, A.; Kopf, M.; Iwakura, Y.; Matsuda, K.; Arimura, A.; Shioda, S., Pituitary adenylate cyclase-activating polypeptide (PACAP) decreases ischemic neuronal cell death in association with IL-6. Proc. Natl. Acad. Sci. USA, 2006, 103 (19), 7488-7493.
138. Zeng, X. J.; Yu, S. P.; Zhang, L.; Wei, L., Neuroprotective effect of the endogenous neural peptide apelin in cultured mouse cortical neurons. Exp. Cell. Res., 2010, 316 (11), 1773-1783.
139. O'Donnell, L. A.; Agrawal, A.; Sabnekar, P.; Dichter, M. A.; Lynch, D. R.; Kolson, D. L., Apelin, an endogenous neuronal peptide, protects hippocampal neurons against excitotoxic injury. J. Neurochem., 2007, 102 (6), 1905-1917.
140. Jia, J.; Chen, X.; Zhu, W.; Luo, Y.; Hua, Z.; Xu, Y., CART protects brain from damage through ERK activation in ischemic stroke. Neuropeptides, 2008, 42 (5-6), 653-661.
141. Xu, Y.; Zhang, W.; Klaus, J.; Young, J.; Koerner, I.; Sheldahl, L. C.; Hurn, P. D.; Martinez-Murillo, F.; Alkayed, N. J., Role of cocaine- and amphetamine-regulated transcript in estradiolmediated neuroprotection. Proc. Natl. Acad. Sci. USA, 2006, 103 (39), 14489-14494.
142. Park, E. M.; Cho, S.; Frys, K. A.; Glickstein, S. B.; Zhou, P.; Anrather, J.; Ross, M. E.; Iadecola, C., Inducible nitric oxide synthase contributes to gender differences in ischemic brain injury. J. Cereb. Blood Flow Metab., 2006, 26 (3), 392-401.
143. Dominguez, R.; Hu, E.; Zhou, M.; Baudry, M., 17beta-estradiolmediated neuroprotection and ERK activation require a pertussis toxin-sensitive mechanism involving GRK2 and beta-arrestin-1. J. Neurosci., 2009, 29 (13), 4228-4238.
144. Lebesgue, D.; Chevaleyre, V.; Zukin, R. S.; Etgen, A. M., Estradiol rescues neurons from global ischemia-induced cell death: multiple cellular pathways of neuroprotection. Steroids, 2009, 74 (7), 555-561.
145. Ashwell, J. D., The many paths to p38 mitogen-activated protein kinase activation in the immune system. Nat. Rev. Immunol., 2006, 6 (7), 532-540.
146. Allen, M.; Svensson, L.; Roach, M.; Hambor, J.; McNeish, J.; Gabel, C. A., Deficiency of the stress kinase p38alpha results in embryonic lethality: characterization of the kinase dependence of stress responses of enzyme-deficient embryonic stem cells. J. Exp. Med., 2000, 191 (5), 859-870.
147. [Kaech, S.; Banker, G.; Stork, P., Putting on the RITz. Sci. STKE, 2007, 2007 (416), pe71.
148. Zhao, Z. Q.; Vinten-Johansen, J., Postconditioning: reduction of reperfusion-induced injury. Cardiovasc. Res., 2006, 70 (2), 200-211.
149. Cuenda, A.; Rousseau, S., p38 MAP-kinases pathway regulation, function and role in human diseases. Biochim. Biophys. Acta, 2007, 1773 (8), 1358-1375.
150. Sugino, T.; Nozaki, K.; Takagi, Y.; Hattori, I.; Hashimoto, N.; Moriguchi, T.; Nishida, E., Activation of mitogen-activated protein kinases after transient forebrain ischemia in gerbil hippocampus. J. Neurosci., 2000, 20 (12), 4506-4514.
151. Park, S. Y.; Lee, H.; Hur, J.; Kim, S. Y.; Kim, H.; Park, J. H.; Cha, S.; Kang, S. S.; Cho, G. J.; Choi, W. S.; Suk, K., Hypoxia induces nitric oxide production in mouse microglia via p38 mitogenactivated protein kinase pathway. Brain Res. Mol. Brain Res., 2002, 107 (1), 9-16.
152. Hee Han, B.; Choi, J.; Holtzman, D. M., Evidence that p38 mitogen-activated protein kinase contributes to neonatal hypoxicischemic brain injury. Dev. Neurosci., 2002, 24 (5), 405-410.
153. Piao, C. S.; Che, Y.; Han, P. L.; Lee, J. K., Delayed and differential induction of p38 MAPK isoforms in microglia and astrocytes in the brain after transient global ischemia. Brain Res. Mol. Brain Res., 2002, 107 (2), 137-144.
154. Piao, C. S.; Kim, J. B.; Han, P. L.; Lee, J. K., Administration of the p38 MAPK inhibitor SB203580 affords brain protection with a wide therapeutic window against focal ischemic insult. J. Neurosci. Res., 2003, 73 (4), 537-544.
155. Piao, C. S.; Yu, Y. M.; Han, P. L.; Lee, J. K., Dynamic expression of p38beta MAPK in neurons and astrocytes after transient focal ischemia. Brain Res., 2003, 976 (1), 120-124.
156. Nito, C.; Kamada, H.; Endo, H.; Niizuma, K.; Myer, D. J.; Chan, P. H., Role of the p38 mitogen-activated protein kinase/cytosolic phospholipase A2 signaling pathway in blood-brain barrier disruption after focal cerebral ischemia and reperfusion. J. Cereb. Blood Flow Metab., 2008, 28 (10), 1686-1696.
157. Barone, F. C.; Irving, E. A.; Ray, A. M.; Lee, J. C.; Kassis, S.; Kumar, S.; Badger, A. M.; Legos, J. J.; Erhardt, J. A.; Ohlstein, E. H.; Hunter, A. J.; Harrison, D. C.; Philpott, K.; Smith, B. R.; Adams, J. L.; Parsons, A. A., Inhibition of p38 mitogen-activated protein kinase provides neuroprotection in cerebral focal ischemia. Med. Res. Rev., 2001, 21 (2), 129-145.
158. Barone, F. C.; Irving, E. A.; Ray, A. M.; Lee, J. C.; Kassis, S.; Kumar, S.; Badger, A. M.; White, R. F.; McVey, M. J.; Legos, J. J.; Erhardt, J. A.; Nelson, A. H.; Ohlstein, E. H.; Hunter, A. J.; Ward, K.; Smith, B. R.; Adams, J. L.; Parsons, A. A., SB 239063, a second-generation p38 mitogen-activated protein kinase inhibitor, reduces brain injury and neurological deficits in cerebral focal ischemia. J. Pharmacol. Exp. Ther., 2001, 296 (2), 312-321.
159. Legos, J. J.; Erhardt, J. A.; White, R. F.; Lenhard, S. C.; Chandra, S.; Parsons, A. A.; Tuma, R. F.; Barone, F. C., SB 239063, a novel p38 inhibitor, attenuates early neuronal injury following ischemia. Brain Res., 2001, 892 (1), 70-77.
160. Legos, J. J.; McLaughlin, B.; Skaper, S. D.; Strijbos, P. J.; Parsons, A. A.; Aizenman, E.; Herin, G. A.; Barone, F. C.; Erhardt, J. A., The selective p38 inhibitor SB-239063 protects primary neurons from mild to moderate excitotoxic injury. Eur. J. Pharmacol., 2002, 447 (1), 37-42.
161. Ha, S. K.; Lee, P.; Park, J. A.; Oh, H. R.; Lee, S. Y.; Park, J. H.; Lee, E. H.; Ryu, J. H.; Lee, K. R.; Kim, S. Y., Apigenin inhibits the production of NO and PGE2 in microglia and inhibits neuronal cell death in a middle cerebral artery occlusion-induced focal ischemia mice model. Neurochem. Int., 2008, 52 (4-5), 878-886.
162. Kishimoto, K.; Li, R. C.; Zhang, J.; Klaus, J. A.; Kibler, K. K.; Dore, S.; Koehler, R. C.; Sapirstein, A., Cytosolic phospholipase A2 alpha amplifies early cyclooxygenase-2 expression, oxidative stress and MAP kinase phosphorylation after cerebral ischemia in mice. J. Neuroinflammation, 2010, 7, 42.
163. Cui, L.; Zhang, X.; Yang, R.; Wang, L.; Liu, L.; Li, M.; Du, W., Neuroprotection of early and short-time applying atorvastatin in the acute phase of cerebral ischemia: down-regulated 12/15-LOX, p38MAPK and cPLA2 expression, ameliorated BBB permeability. Brain Res., 2010, 1325, 164-173.
164. Lee, S. R.; Lo, E. H., Interactions between p38 mitogen-activated protein kinase and caspase-3 in cerebral endothelial cell death after hypoxia-reoxygenation. Stroke, 2003, 34 (11), 2704-2709.
165. Ostrowski, R. P.; Graupner, G.; Titova, E.; Zhang, J.; Chiu, J.; Dach, N.; Corleone, D.; Tang, J.; Zhang, J. H., The hyperbaric oxygen preconditioning-induced brain protection is mediated by a reduction of early apoptosis after transient global cerebral ischemia. Neurobiol. Dis., 2008, 29 (1), 1-13.
166. Yamashita, S.; Hirata, T.; Mizukami, Y.; Cui, Y. J.; Fukuda, S.; Ishida, K.; Matsumoto, M.; Sakabe, T., Repeated preconditioning with hyperbaric oxygen induces neuroprotection against forebrain ischemia via suppression of p38 mitogen activated protein kinase. Brain Res., 2009, 1301, 171-179.
167. Park, J. Y.; Kim, E. J.; Kwon, K. J.; Jung, Y. S.; Moon, C. H.; Lee, S. H.; Baik, E. J., Neuroprotection by fructose-1,6-bisphosphate involves ROS alterations via p38 MAPK/ERK. Brain Res., 2004, 1026 (2), 295-301.
168. Hattori, I.; Takagi, Y.; Nakamura, H.; Nozaki, K.; Bai, J.; Kondo, N.; Sugino, T.; Nishimura, M.; Hashimoto, N.; Yodoi, J., Intravenous administration of thioredoxin decreases brain damage following transient focal cerebral ischemia in mice. Antioxid. Redox Signal., 2004, 6 (1), 81-87.
169. Melani, A.; Gianfriddo, M.; Vannucchi, M. G.; Cipriani, S.; Baraldi, P. G.; Giovannini, M. G.; Pedata, F., The selective A2A receptor antagonist SCH 58261 protects from neurological deficit, brain damage and activation of p38 MAPK in rat focal cerebral ischemia. Brain Res., 2006, 1073-1074, 470-480.
170. Mukerji, S. S.; Rainey, R. N.; Rhodes, J. L.; Hall, A. K., Delayed activin A administration attenuates tissue death after transient focal cerebral ischemia and is associated with decreased stressresponsive kinase activation. J. Neurochem., 2009, 111 (5), 1138-1148.
171. Pedata, F.; Gianfriddo, M.; Turchi, D.; Melani, A., The protective effect of adenosine A2A receptor antagonism in cerebral ischemia. Neurol. Res., 2005, 27 (2), 169-174.
172. Nishimura, M.; Sugino, T.; Nozaki, K.; Takagi, Y.; Hattori, I.; Hayashi, J.; Hashimoto, N.; Moriguchi, T.; Nishida, E., Activation of p38 kinase in the gerbil hippocampus showing ischemic tolerance. J. Cereb. Blood Flow Metab., 2003, 23 (9), 1052-1059.
173. Sun, X. C.; Li, W. B.; Li, Q. J.; Zhang, M.; Xian, X. H.; Qi, J.; Jin, R. L.; Li, S. Q., Limb ischemic preconditioning induces brain ischemic tolerance via p38 MAPK. Brain Res., 2006, 1084 (1), 165-174.
174. Zheng, S.; Zuo, Z., Isoflurane preconditioning induces neuroprotection against ischemia via activation of P38 mitogenactivated protein kinases. Mol. Pharmacol., 2004, 65 (5), 1172-1180.
175. Lennmyr, F.; Ericsson, A.; Gerwins, P.; Ahlstrom, H.; Terent, A., Increased brain injury and vascular leakage after pretreatment with p38-inhibitor SB203580 in transient ischemia. Acta Neurol. Scand., 2003, 108 (5), 339-345.
176. Chen, J.; Li, C.; Pei, D. S.; Han, D.; Liu, X. M.; Jiang, H. X.; Wang, X. T.; Guan, Q. H.; Wen, X. R.; Hou, X. Y.; Zhang, G. Y., GluR6-containing KA receptor mediates the activation of p38 MAP kinase in rat hippocampal CA1 region during brain ischemia injury. Hippocampus, 2009, 19 (1), 79-89.
177. Harada, C.; Nakamura, K.; Namekata, K.; Okumura, A.; Mitamura, Y.; Iizuka, Y.; Kashiwagi, K.; Yoshida, K.; Ohno, S.; Matsuzawa, A.; Tanaka, K.; Ichijo, H.; Harada, T., Role of apoptosis signalregulating kinase 1 in stress-induced neural cell apoptosis in vivo. Am. J. Pathol., 2006, 168 (1), 261-269.
178. Takeda, K.; Hatai, T.; Hamazaki, T. S.; Nishitoh, H.; Saitoh, M.; Ichijo, H., Apoptosis signal-regulating kinase 1 (ASK1) induces neuronal differentiation and survival of PC12 cells. J. Biol. Chem., 2000, 275 (13), 9805-9813.
179. Takeda, K.; Matsuzawa, A.; Nishitoh, H.; Tobiume, K.; Kishida, S.; Ninomiya-Tsuji, J.; Matsumoto, K.; Ichijo, H., Involvement of ASK1 in Ca2+-induced p38 MAP kinase activation. EMBO Rep., 2004, 5 (2), 161-166.
180. Saitoh, M.; Nishitoh, H.; Fujii, M.; Takeda, K.; Tobiume, K.; Sawada, Y.; Kawabata, M.; Miyazono, K.; Ichijo, H., Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1. Embo J., 1998, 17 (9), 2596-2606.
181. Tobiume, K.; Matsuzawa, A.; Takahashi, T.; Nishitoh, H.; Morita, K.; Takeda, K.; Minowa, O.; Miyazono, K.; Noda, T.; Ichijo, H., ASK1 is required for sustained activations of JNK/p38 MAP kinases and apoptosis. EMBO Rep., 2001, 2 (3), 222-228.
182. Zhang, Q.; Zhang, G., Activation and autophosphorylation of apoptosis signal-regulating kinase 1 (ASK1) following cerebral ischemia in rat hippocampus. Neurosci. Lett., 2002, 329 (2), 232-236.
183. Yang, C.; Ren, Y.; Liu, F.; Cai, W.; Zhang, N.; Nagel, D. J.; Yin, G., Ischemic preconditioning suppresses apoptosis of rabbit spinal neurocytes by inhibiting ASK1-14-3-3 dissociation. Neurosci. Lett., 2008, 441 (3), 267-271.
184. Wang, X.; Xu, L.; Wang, H.; Young, P. R.; Gaestel, M.; Feuerstein, G. Z., Mitogen-activated protein kinase-activated protein (MAPKAP) kinase 2 deficiency protects brain from ischemic injury in mice. J. Biol. Chem., 2002, 277 (46), 43968-43972.
185. Shiroto, K.; Otani, H.; Yamamoto, F.; Huang, C. K.; Maulik, N.; Das, D. K., MK2-/- gene knockout mouse hearts carry antiapoptotic signal and are resistant to ischemia reperfusion injury. J. Mol. Cell. Cardiol., 2005, 38 (1), 93-97.
186. Fryer, R. M.; Patel, H. H.; Hsu, A. K.; Gross, G. J., Stress-activated protein kinase phosphorylation during cardioprotection in the ischemic myocardium. Am. J. Physiol. Heart Circ. Physiol., 2001, 281 (3), H1184-1192.
187. Nakano, A.; Baines, C. P.; Kim, S. O.; Pelech, S. L.; Downey, J. M.; Cohen, M. V.; Critz, S. D., Ischemic preconditioning activates MAPKAPK2 in the isolated rabbit heart: evidence for involvement of p38 MAPK. Circ. Res., 2000, 86 (2), 144-151.
188. Mocanu, M. M.; Baxter, G. F.; Yue, Y.; Critz, S. D.; Yellon, D. M., The p38 MAPK inhibitor, SB203580, abrogates ischaemic preconditioning in rat heart but timing of administration is critical. Basic Res. Cardiol., 2000, 95 (6), 472-478.
189. Stetler, R. A.; Gao, Y.; Signore, A. P.; Cao, G.; Chen, J., HSP27: mechanisms of cellular protection against neuronal injury. Curr. Mol. Med., 2009, 9 (7), 863-872.
190. Valentim, L. M.; Geyer, A. B.; Tavares, A.; Cimarosti, H.; Worm, P. V.; Rodnight, R.; Netto, C. A.; Salbego, C. G., Effects of global cerebral ischemia and preconditioning on heat shock protein 27 immunocontent and phosphorylation in rat hippocampus. Neuroscience, 2001, 107 (1), 43-49.
191. Valentim, L. M.; Rodnight, R.; Geyer, A. B.; Horn, A. P.; Tavares, A.; Cimarosti, H.; Netto, C. A.; Salbego, C. G., Changes in heat shock protein 27 phosphorylation and immunocontent in response to preconditioning to oxygen and glucose deprivation in organotypic hippocampal cultures. Neuroscience, 2003, 118 (2), 379-386.
192. Akbar, M. T.; Lundberg, A. M.; Liu, K.; Vidyadaran, S.; Wells, K. E.; Dolatshad, H.; Wynn, S.; Wells, D. J.; Latchman, D. S.; de Belleroche, J., The neuroprotective effects of heat shock protein 27 overexpression in transgenic animals against kainate-induced seizures and hippocampal cell death. J. Biol. Chem., 2003, 278 (22), 19956-19965.
193. Bruey, J. M.; Ducasse, C.; Bonniaud, P.; Ravagnan, L.; Susin, S. A.; Diaz-Latoud, C.; Gurbuxani, S.; Arrigo, A. P.; Kroemer, G.; Solary, E.; Garrido, C., Hsp27 negatively regulates cell death by interacting with cytochrome c. Nat. Cell. Biol., 2000, 2 (9), 645-652.
194. Nagy, N.; Shiroto, K.; Malik, G.; Huang, C. K.; Gaestel, M.; Abdellatif, M.; Tosaki, A.; Maulik, N.; Das, D. K., Ischemic preconditioning involves dual cardio-protective axes with p38MAPK as upstream target. J. Mol. Cell. Cardiol., 2007, 42 (5), 981-990.
195. Wang, X.; Destrument, A.; Tournier, C., Physiological roles of MKK4 and MKK7: insights from animal models. Biochim. Biophys. Acta, 2007, 1773 (8), 1349-1357.
196. Bogoyevitch, M. A.; Arthur, P. G., Inhibitors of c-Jun N-terminal kinases: JuNK no more? Biochim. Biophys. Acta, 2008, 1784 (1), 76-93.
197. Shackelford, D. A.; Yeh, R. Y., Modulation of ERK and JNK activity by transient forebrain ischemia in rats. J. Neurosci. Res., 2006, 83 (3), 476-488.
198. Shackelford, D. A.; Yeh, R. Y., Differential effects of ischemia and reperfusion on c-Jun N-terminal kinase isoform protein and activity. Brain Res. Mol. Brain Res., 2001, 94 (1-2), 178-192.
199. Kuan, C. Y.; Whitmarsh, A. J.; Yang, D. D.; Liao, G.; Schloemer, A. J.; Dong, C.; Bao, J.; Banasiak, K. J.; Haddad, G. G.; Flavell, R. A.; Davis, R. J.; Rakic, P., A critical role of neural-specific JNK3 for ischemic apoptosis. Proc. Natl. Acad. Sci. USA, 2003, 100 (25), 15184-15189.
200. Pirianov, G.; Brywe, K. G.; Mallard, C.; Edwards, A. D.; Flavell, R. A.; Hagberg, H.; Mehmet, H., Deletion of the c-Jun N-terminal kinase 3 gene protects neonatal mice against cerebral hypoxicischaemic injury. J. Cereb. Blood Flow Metab., 2007, 27 (5), 1022-1032.
201. Thornton, T. M.; Pedraza-Alva, G.; Deng, B.; Wood, C. D.; Aronshtam, A.; Clements, J. L.; Sabio, G.; Davis, R. J.; Matthews, D. E.; Doble, B.; Rincon, M., Phosphorylation by p38 MAPK as an alternative pathway for GSK3beta inactivation. Science, 2008, 320 (5876), 667-670.
202. Chan, E. D.; Riches, D. W., Potential role of the JNK/SAPK signal transduction pathway in the induction of iNOS by TNF-alpha. Biochem. Biophys. Res. Commun., 1998, 253 (3), 790-796.
203. Guan, Q. H.; Pei, D. S.; Liu, X. M.; Wang, X. T.; Xu, T. L.; Zhang, G. Y., Neuroprotection against ischemic brain injury by SP600125 via suppressing the extrinsic and intrinsic pathways of apoptosis. Brain Res., 2006, 1092 (1), 36-46.
204. Guan, Q. H.; Pei, D. S.; Zhang, Q. G.; Hao, Z. B.; Xu, T. L.; Zhang, G. Y., The neuroprotective action of SP600125, a new inhibitor of JNK, on transient brain ischemia/reperfusion-induced neuronal death in rat hippocampal CA1 via nuclear and nonnuclear pathways. Brain Res., 2005, 1035 (1), 51-59.
205. Okuno, S.; Saito, A.; Hayashi, T.; Chan, P. H., The c-Jun Nterminal protein kinase signaling pathway mediates Bax activation and subsequent neuronal apoptosis through interaction with Bim after transient focal cerebral ischemia. J. Neurosci., 2004, 24 (36), 7879-7887.
206. Gao, Y.; Signore, A. P.; Yin, W.; Cao, G.; Yin, X. M.; Sun, F.; Luo, Y.; Graham, S. H.; Chen, J., Neuroprotection against focal ischemic brain injury by inhibition of c-Jun N-terminal kinase and attenuation of the mitochondrial apoptosis-signaling pathway. J. Cereb. Blood Flow Metab., 2005, 25 (6), 694-712.
207. Carboni, S.; Antonsson, B.; Gaillard, P.; Gotteland, J. P.; Gillon, J. Y.; Vitte, P. A., Control of death receptor and mitochondrialdependent apoptosis by c-Jun N-terminal kinase in hippocampal CA1 neurones following global transient ischaemia. J. Neurochem., 2005, 92 (5), 1054-1060.
208. Carboni, S.; Boschert, U.; Gaillard, P.; Gotteland, J. P.; Gillon, J. Y.; Vitte, P. A., AS601245, a c-Jun NH2-terminal kinase (JNK) inhibitor, reduces axon/dendrite damage and cognitive deficits after global cerebral ischaemia in gerbils. Br. J. Pharmacol., 2008, 153 (1), 157-163.
209. Carboni, S.; Hiver, A.; Szyndralewiez, C.; Gaillard, P.; Gotteland, J. P.; Vitte, P. A., AS601245 (1,3-benzothiazol-2-yl (2-[[2-(3- pyridinyl) ethyl] amino]-4 pyrimidinyl) acetonitrile): a c-Jun NH2- terminal protein kinase inhibitor with neuroprotective properties. J. Pharmacol. Exp. Ther., 2004, 310 (1), 25-32.
210. Dickens, M.; Rogers, J. S.; Cavanagh, J.; Raitano, A.; Xia, Z.; Halpern, J. R.; Greenberg, M. E.; Sawyers, C. L.; Davis, R. J., A cytoplasmic inhibitor of the JNK signal transduction pathway. Science, 1997, 277 (5326), 693-696.
211. Hayashi, T.; Sakai, K.; Sasaki, C.; Zhang, W. R.; Warita, H.; Abe, K., c-Jun N-terminal kinase (JNK) and JNK interacting protein response in rat brain after transient middle cerebral artery occlusion. Neurosci. Lett., 2000, 284 (3), 195-199.
212. Hirt, L.; Badaut, J.; Thevenet, J.; Granziera, C.; Regli, L.; Maurer, F.; Bonny, C.; Bogousslavsky, J., D-JNKI1, a cell-penetrating c- Jun-N-terminal kinase inhibitor, protects against cell death in severe cerebral ischemia. Stroke, 2004, 35 (7), 1738-1743.
213. Borsello, T.; Clarke, P. G.; Hirt, L.; Vercelli, A.; Repici, M.; Schorderet, D. F.; Bogousslavsky, J.; Bonny, C., A peptide inhibitor of c-Jun N-terminal kinase protects against excitotoxicity and cerebral ischemia. Nat. Med., 2003, 9 (9), 1180-1186.
214. Liu, J. R.; Zhao, Y.; Patzer, A.; Staak, N.; Boehm, R.; Deuschl, G.; Culman, J.; Bonny, C.; Herdegen, T.; Eschenfelder, C., The c-Jun N-terminal kinase (JNK) inhibitor XG-102 enhances the neuroprotection of hyperbaric oxygen after cerebral ischaemia in adult rats. Neuropathol. Appl. Neurobiol., 2010, 36 (3), 211-224.
215. Esneault, E.; Castagne, V.; Moser, P.; Bonny, C.; Bernaudin, M., D-JNKi, a peptide inhibitor of c-Jun N-terminal kinase, promotes functional recovery after transient focal cerebral ischemia in rats. Neuroscience, 2008, 152 (2), 308-320.
216. Stetler, R. A.; Cao, G.; Gao, Y.; Zhang, F.; Wang, S.; Weng, Z.; Vosler, P.; Zhang, L.; Signore, A.; Graham, S. H.; Chen, J., Hsp27 protects against ischemic brain injury via attenuation of a novel stress-response cascade upstream of mitochondrial cell death signaling. J. Neurosci., 2008, 28 (49), 13038-13055.
217. Wen, X. R.; Li, C.; Zong, Y. Y.; Yu, C. Z.; Xu, J.; Han, D.; Zhang, G. Y., Dual inhibitory roles of geldanamycin on the c-Jun NH2- terminal kinase 3 signal pathway through suppressing the expression of mixed-lineage kinase 3 and attenuating the activation of apoptosis signal-regulating kinase 1 via facilitating the activation of Akt in ischemic brain injury. Neuroscience, 2008, 156 (3), 483-497.
218. Zhang, Q. G.; Wang, R.; Han, D.; Dong, Y.; Brann, D. W., Role of Rac1 GTPase in JNK signaling and delayed neuronal cell death following global cerebral ischemia. Brain Res., 2009, 1265, 138-147.
219. Tian, H.; Zhang, Q. G.; Zhu, G. X.; Pei, D. S.; Guan, Q. H.; Zhang, G. Y., Activation of c-Jun NH2-terminal kinase 3 is mediated by the GluR6.PSD-95.MLK3 signaling module following cerebral ischemia in rat hippocampus. Brain Res., 2005, 1061 (1), 57-66.
220. Hu, S. Q.; Zhu, J.; Pei, D. S.; Zong, Y. Y.; Yan, J. Z.; Hou, X. Y.; Zhang, G. Y., Overexpression of the PDZ1 domain of PSD-95 diminishes ischemic brain injury via inhibition of the GluR6.PSD-95.MLK3 pathway. J. Neurosci. Res., 2009, 87 (16), 3626-3638.
221. Du, Y.; Li, C.; Hu, W. W.; Song, Y. J.; Zhang, G. Y., Neuroprotection of preconditioning against ischemic brain injury in rat hippocampus through inhibition of the assembly of GluR6- PSD95-mixed lineage kinase 3 signaling module via nuclear and non-nuclear pathways. Neuroscience, 2009, 161 (2), 370-380.
222. Hu, W. W.; Du, Y.; Li, C.; Song, Y. J.; Zhang, G. Y., Neuroprotection of hypothermia against neuronal death in rat hippocampus through inhibiting the increased assembly of GluR6- PSD95-MLK3 signaling module induced by cerebral ischemia/reperfusion. Hippocampus, 2008, 18 (4), 386-397.
223. Zhang, Q. G.; Tian, H.; Li, H. C.; Zhang, G. Y., Antioxidant Nacetylcysteine inhibits the activation of JNK3 mediated by the GluR6-PSD95-MLK3 signaling module during cerebral ischemia in rat hippocampus. Neurosci. Lett., 2006, 408 (3), 159-164.
224. Mehta, S.; Wu, H.; Garner, C. C.; Marshall, J., Molecular mechanisms regulating the differential association of kainate receptor subunits with SAP90/PSD-95 and SAP97. J. Biol. Chem., 2001, 276 (19), 16092-16099.
225. Yu, C. Z.; Li, C.; Pei, D. S.; Zong, Y. Y.; Shi, Q.; Wen, X. R.; Guan, Q. H.; Hang, D.; Hou, X. Y.; Zhang, G. Y., Neuroprotection against transient focal cerebral ischemia and oxygen-glucose deprivation by interference with GluR6-PSD95 protein interaction. Neurochem. Res., 2009, 34 (11), 2008-2021.
226. Zhang, Q. X.; Pei, D. S.; Guan, Q. H.; Sun, Y. F.; Liu, X. M.; Zhang, G. Y., Crosstalk between PSD-95 and JIP1-mediated signaling modules: the mechanism of MLK3 activation in cerebral ischemia. Biochemistry, 2007, 46 (13), 4006-4016.
227. Brazil, D. P.; Hemmings, B. A., Ten years of protein kinase B signalling: a hard Akt to follow. Trends Biochem. Sci., 2001, 26 (11), 657-664.
228. [Vanhaesebroeck, B.; Alessi, D. R., The PI3K-PDK1 connection: more than just a road to PKB. Biochem. J., 2000, 346 Pt 3, 561-576.
229. Dong, L. Q.; Liu, F., PDK2: the missing piece in the receptor tyrosine kinase signaling pathway puzzle. Am. J. Physiol. Endocrinol. Metab., 2005, 289 (2), E187-196.
230. Sasaki, A. T.; Firtel, R. A., Regulation of chemotaxis by the orchestrated activation of Ras, PI3K, and TOR. Eur. J. Cell. Biol., 2006, 85 (9-10), 873-895.
231. Vanhaesebroeck, B.; Guillermet-Guibert, J.; Graupera, M.; Bilanges, B., The emerging mechanisms of isoform-specific PI3K signalling. Nat. Rev. Mol. Cell. Biol., 2010, 11 (5), 329-341.
232. Wymann, M. P.; Pirola, L., Structure and function of phosphoinositide 3-kinases. Biochim. Biophys. Acta, 1998, 1436 (1-2), 127-150.
233. Hawkins, P. T.; Anderson, K. E.; Davidson, K.; Stephens, L. R., Signalling through Class I PI3Ks in mammalian cells. Biochem. Soc. Trans., 2006, 34 (Pt 5), 647-662.
234. Jin, E.; Nosaka, K.; Sano, M., NGF-dependent formation of ruffles in PC12D cells required a different pathway from that for neurite outgrowth. Neurochem. Int., 2007, 51 (2-4), 216-226.
235. Saito, A.; Narasimhan, P.; Hayashi, T.; Okuno, S.; Ferrand-Drake, M.; Chan, P. H., Neuroprotective role of a proline-rich Akt substrate in apoptotic neuronal cell death after stroke: relationships with nerve growth factor. J. Neurosci., 2004, 24 (7), 1584-1593.
236. Jang, S. W.; Okada, M.; Sayeed, I.; Xiao, G.; Stein, D.; Jin, P.; Ye, K., Gambogic amide, a selective agonist for TrkA receptor that possesses robust neurotrophic activity, prevents neuronal cell death. Proc. Natl. Acad. Sci. USA, 2007, 104 (41), 16329-16334.
237. Almeida, R. D.; Manadas, B. J.; Melo, C. V.; Gomes, J. R.; Mendes, C. S.; Graos, M. M.; Carvalho, R. F.; Carvalho, A. P.; Duarte, C. B., Neuroprotection by BDNF against glutamateinduced apoptotic cell death is mediated by ERK and PI3-kinase pathways. Cell Death Differ., 2005, 12 (10), 1329-1343.
238. Jin, G.; Omori, N.; Li, F.; Nagano, I.; Manabe, Y.; Shoji, M.; Abe, K., Protection against ischemic brain damage by GDNF affecting cell survival and death signals. Neurol. Res., 2003, 25 (3), 249-253.
239. Sun, F. Y.; Guo, X., Molecular and cellular mechanisms of neuroprotection by vascular endothelial growth factor. J. Neurosci. Res., 2005, 79 (1-2), 180-184.
240. Kilic, E.; Kilic, U.; Wang, Y.; Bassetti, C. L.; Marti, H. H.; Hermann, D. M., The phosphatidylinositol-3 kinase/Akt pathway mediates VEGF's neuroprotective activity and induces blood brain barrier permeability after focal cerebral ischemia. FASEB J., 2006, 20 (8), 1185-1187.
241. Atkinson, T.; Whitfield, J.; Chakravarthy, B., The phosphatase inhibitor, okadaic acid, strongly protects primary rat cortical neurons from lethal oxygen-glucose deprivation. Biochem. Biophys. Res. Commun., 2009, 378 (3), 394-398.
242. Perkinton, M. S.; Ip, J. K.; Wood, G. L.; Crossthwaite, A. J.; Williams, R. J., Phosphatidylinositol 3-kinase is a central mediator of NMDA receptor signalling to MAP kinase (Erk1/2), Akt/PKB and CREB in striatal neurones. J. Neurochem., 2002, 80 (2), 239-254.
243. Sutton, G.; Chandler, L. J., Activity-dependent NMDA receptormediated activation of protein kinase B/Akt in cortical neuronal cultures. J. Neurochem., 2002, 82 (5), 1097-1105.
244. Finkbeiner, S.; Greenberg, M. E., Ca(2+)-dependent routes to Ras: mechanisms for neuronal survival, differentiation, and plasticity? Neuron, 1996, 16 (2), 233-236.
245. Li, J.; Lang, J.; Zeng, Z.; McCullough, L. D., Akt1 gene deletion and stroke. J. Neurol. Sci., 2008, 269 (1-2), 105-112.
246. Kitagawa, H.; Warita, H.; Sasaki, C.; Zhang, W. R.; Sakai, K.; Shiro, Y.; Mitsumoto, Y.; Mori, T.; Abe, K., Immunoreactive Akt, PI3-K and ERK protein kinase expression in ischemic rat brain. Neurosci. Lett., 1999, 274 (1), 45-48.
247. Noshita, N.; Lewen, A.; Sugawara, T.; Chan, P. H., Evidence of phosphorylation of Akt and neuronal survival after transient focal cerebral ischemia in mice. J. Cereb. Blood Flow Metab., 2001, 21 (12), 1442-1450.
248. Shibata, M.; Yamawaki, T.; Sasaki, T.; Hattori, H.; Hamada, J.; Fukuuchi, Y.; Okano, H.; Miura, M., Upregulation of Akt phosphorylation at the early stage of middle cerebral artery occlusion in mice. Brain Res., 2002, 942 (1-2), 1-10.
249. Miyawaki, T.; Ofengeim, D.; Noh, K. M.; Latuszek-Barrantes, A.; Hemmings, B. A.; Follenzi, A.; Zukin, R. S., The endogenous inhibitor of Akt, CTMP, is critical to ischemia-induced neuronal death. Nat. Neurosci., 2009, 12 (5), 618-626.
250. Luo, H. R.; Hattori, H.; Hossain, M. A.; Hester, L.; Huang, Y.; Lee-Kwon, W.; Donowitz, M.; Nagata, E.; Snyder, S. H., Akt as a mediator of cell death. Proc. Natl. Acad. Sci. USA, 2003, 100 (20), 11712-11717.
251. Ohba, N.; Kiryu-Seo, S.; Maeda, M.; Muraoka, M.; Ishii, M.; Kiyama, H., Transgenic mouse overexpressing the Akt reduced the volume of infarct area after middle cerebral artery occlusion. Neurosci. Lett., 2004, 359 (3), 159-162.
252. Wang, X. T.; Pei, D. S.; Xu, J.; Guan, Q. H.; Sun, Y. F.; Liu, X. M.; Zhang, G. Y., Opposing effects of Bad phosphorylation at two distinct sites by Akt1 and JNK1/2 on ischemic brain injury. Cell. Signal., 2007, 19 (9), 1844-1856.
253. [Kim, D.; Shu, S.; Coppola, M. D.; Kaneko, S.; Yuan, Z. Q.; Cheng, J. Q., Regulation of proapoptotic mammalian ste20-like kinase MST2 by the IGF1-Akt pathway. PLoS One, 2010, 5 (3), e9616.
254. Jang, S. W.; Yang, S. J.; Srinivasan, S.; Ye, K., Akt phosphorylates MstI and prevents its proteolytic activation, blocking FOXO3 phosphorylation and nuclear translocation. J. Biol. Chem., 2007, 282 (42), 30836-30844.
255. Fresno Vara, J. A.; Casado, E.; de Castro, J.; Cejas, P.; Belda- Iniesta, C.; Gonzalez-Baron, M., PI3K/Akt signalling pathway and cancer. Cancer Treat. Rev., 2004, 30 (2), 193-204.
256. Hui, L.; Pei, D. S.; Zhang, Q. G.; Guan, Q. H.; Zhang, G. Y., The neuroprotection of insulin on ischemic brain injury in rat hippocampus through negative regulation of JNK signaling pathway by PI3K/Akt activation. Brain Res., 2005, 1052 (1), 1-9.
257. Zhang, Q. G.; Wu, D. N.; Han, D.; Zhang, G. Y., Critical role of PTEN in the coupling between PI3K/Akt and JNK1/2 signaling in ischemic brain injury. FEBS Lett., 2007, 581 (3), 495-505.
258. Wang, R.; Zhang, Q. G.; Han, D.; Xu, J.; Lu, Q.; Zhang, G. Y., Inhibition of MLK3-MKK4/7-JNK1/2 pathway by Akt1 in exogenous estrogen-induced neuroprotection against transient global cerebral ischemia by a non-genomic mechanism in male rats. J. Neurochem., 2006, 99 (6), 1543-1554.
259. Papadia, S.; Soriano, F. X.; Leveille, F.; Martel, M. A.; Dakin, K. A.; Hansen, H. H.; Kaindl, A.; Sifringer, M.; Fowler, J.; Stefovska, V.; McKenzie, G.; Craigon, M.; Corriveau, R.; Ghazal, P.; Horsburgh, K.; Yankner, B. A.; Wyllie, D. J.; Ikonomidou, C.; Hardingham, G. E., Synaptic NMDA receptor activity boosts intrinsic antioxidant defenses. Nat. Neurosci., 2008, 11 (4), 476-487.
260. Lipton, S. A., NMDA receptor activity regulates transcription of antioxidant pathways. Nat. Neurosci., 2008, 11 (4), 381-382.
261. Bhaskar, P. T.; Hay, N., The two TORCs and Akt. Dev. Cell, 2007, 12 (4), 487-502.
262. Sun, X.; Yao, H.; Douglas, R. M.; Gu, X. Q.; Wang, J.; Haddad, G. G., Insulin/PI3K signaling protects dentate neurons from oxygenglucose deprivation in organotypic slice cultures. J. Neurochem., 2010, 112 (2), 377-388.
263. Zachary, I., Neuroprotective role of vascular endothelial growth factor: signalling mechanisms, biological function, and therapeutic potential. Neurosignals, 2005, 14 (5), 207-221.
264. Sun, Y.; Jin, K.; Xie, L.; Childs, J.; Mao, X. O.; Logvinova, A.; Greenberg, D. A., VEGF-induced neuroprotection, neurogenesis, and angiogenesis after focal cerebral ischemia. J. Clin. Invest., 2003, 111 (12), 1843-1851.
265. Abe, E.; Fujiki, M.; Nagai, Y.; Shiqi, K.; Kubo, T.; Ishii, K.; Abe, T.; Kobayashi, H., The phosphatidylinositol-3 kinase/Akt pathway mediates geranylgeranylacetone-induced neuroprotection against cerebral infarction in rats. Brain Res., 2010, 1330, 151-157.
266. Zhou, Y.; Lekic, T.; Fathali, N.; Ostrowski, R. P.; Martin, R. D.; Tang, J.; Zhang, J. H., Isoflurane posttreatment reduces neonatal hypoxic-ischemic brain injury in rats by the sphingosine-1- phosphate/phosphatidylinositol-3-kinase/Akt pathway. Stroke, 2010, 41 (7), 1521-1527.
267. Xu, X.; Chua, C. C.; Gao, J.; Chua, K. W.; Wang, H.; Hamdy, R. C.; Chua, B. H., Neuroprotective effect of humanin on cerebral ischemia/reperfusion injury is mediated by a PI3K/Akt pathway. Brain Res., 2008, 1227, 12-18.
268. Cybulski, N.; Hall, M. N., TOR complex 2: a signaling pathway of its own. Trends Biochem. Sci., 2009, 34 (12), 620-627.
269. Rahimi, R. A.; Andrianifahanana, M.; Wilkes, M. C.; Edens, M.; Kottom, T. J.; Blenis, J.; Leof, E. B., Distinct roles for mammalian target of rapamycin complexes in the fibroblast response to transforming growth factor-beta. Cancer Res., 2009, 69 (1), 84-93.
270. Soukas, A. A.; Kane, E. A.; Carr, C. E.; Melo, J. A.; Ruvkun, G., Rictor/TORC2 regulates fat metabolism, feeding, growth, and life span in Caenorhabditis elegans. Genes Dev., 2009, 23 (4), 496-511.
271. Cai, H.; Das, S.; Kamimura, Y.; Long, Y.; Parent, C. A.; Devreotes, P. N., Ras-mediated activation of the TORC2-PKB pathway is critical for chemotaxis. J. Cell. Biol., 2010, 190 (2), 233-245.
272. Charest, P. G.; Shen, Z.; Lakoduk, A.; Sasaki, A. T.; Briggs, S. P.; Firtel, R. A., A Ras signaling complex controls the RasC-TORC2 pathway and directed cell migration. Dev. Cell, 2010, 18 (5), 737-749.
273. Khokhlatchev, A.; Rabizadeh, S.; Xavier, R.; Nedwidek, M.; Chen, T.; Zhang, X. F.; Seed, B.; Avruch, J., Identification of a novel Ras-regulated proapoptotic pathway. Curr. Biol., 2002, 12 (4), 253-265.
274. Vos, M. D.; Clark, G. J., RASSF family proteins and Ras transformation. Methods Enzymol., 2006, 407, 311-322.
275. Cox, A. D.; Der, C. J., The dark side of Ras: regulation of apoptosis. Oncogene, 2003, 22 (56), 8999-9006.
276. Hwang, E.; Ryu, K. S.; Paakkonen, K.; Guntert, P.; Cheong, H. K.; Lim, D. S.; Lee, J. O.; Jeon, Y. H.; Cheong, C., Structural insight into dimeric interaction of the SARAH domains from Mst1 and RASSF family proteins in the apoptosis pathway. Proc. Natl. Acad. Sci. USA, 2007, 104 (22), 9236-9241.
277. Avruch, J.; Praskova, M.; Ortiz-Vega, S.; Liu, M.; Zhang, X. F., Nore1 and RASSF1 regulation of cell proliferation and of the MST1/2 kinases. Methods Enzymol., 2006, 407, 290-310.
278. de Souza, P. M.; Lindsay, M. A., Mammalian Sterile20-like kinase 1 and the regulation of apoptosis. Biochem. Soc. Trans., 2004, 32 (Pt3), 485-488.
279. Praskova, M.; Khoklatchev, A.; Ortiz-Vega, S.; Avruch, J., Regulation of the MST1 kinase by autophosphorylation, by the growth inhibitory proteins, RASSF1 and NORE1, and by Ras. Biochem. J., 2004, 381 (Pt 2), 453-462.
280. Glantschnig, H.; Rodan, G. A.; Reszka, A. A., Mapping of MST1 kinase sites of phosphorylation. Activation and autophosphorylation. J. Biol. Chem., 2002, 277 (45), 42987-42996.
281. Lee, K. K.; Ohyama, T.; Yajima, N.; Tsubuki, S.; Yonehara, S., MST, a physiological caspase substrate, highly sensitizes apoptosis both upstream and downstream of caspase activation. J. Biol. Chem., 2001, 276 (22), 19276-19285.
282. Ura, S.; Masuyama, N.; Graves, J. D.; Gotoh, Y., Caspase cleavage of MST1 promotes nuclear translocation and chromatin condensation. Proc. Natl. Acad. Sci. USA, 2001, 98 (18), 10148-10153.
283. Cheung, W. L.; Ajiro, K.; Samejima, K.; Kloc, M.; Cheung, P.; Mizzen, C. A.; Beeser, A.; Etkin, L. D.; Chernoff, J.; Earnshaw, W. C.; Allis, C. D., Apoptotic phosphorylation of histone H2B is mediated by mammalian sterile twenty kinase. Cell, 2003, 113 (4), 507-517.
284. Ura, S.; Masuyama, N.; Graves, J. D.; Gotoh, Y., MST1-JNK promotes apoptosis via caspase-dependent and independent pathways. Genes Cells, 2001, 6 (6), 519-530.
285. Lehtinen, M. K.; Yuan, Z.; Boag, P. R.; Yang, Y.; Villen, J.; Becker, E. B.; DiBacco, S.; de la Iglesia, N.; Gygi, S.; Blackwell, T. K.; Bonni, A., A conserved MST-FOXO signaling pathway mediates oxidative-stress responses and extends life span. Cell, 2006, 125 (5), 987-1001.
286. Yang, X.; Li, D. M.; Chen, W.; Xu, T., Human homologue of Drosophila lats, LATS1, negatively regulate growth by inducing G(2)/M arrest or apoptosis. Oncogene, 2001, 20 (45), 6516-6523.
287. Chan, E. H.; Nousiainen, M.; Chalamalasetty, R. B.; Schafer, A.; Nigg, E. A.; Sillje, H. H., The Ste20-like kinase Mst2 activates the human large tumor suppressor kinase Lats1. Oncogene, 2005, 24 (12), 2076-2086.
288. Wu, S.; Huang, J.; Dong, J.; Pan, D., hippo encodes a Ste-20 family protein kinase that restricts cell proliferation and promotes apoptosis in conjunction with salvador and warts. Cell, 2003, 114 (4), 445-456.
289. Huang, J.; Wu, S.; Barrera, J.; Matthews, K.; Pan, D., The Hippo signaling pathway coordinately regulates cell proliferation and apoptosis by inactivating Yorkie, the Drosophila Homolog of YAP. Cell, 2005, 122 (3), 421-434.
290. Kitagawa, K., CREB and cAMP response element-mediated gene expression in the ischemic brain. FEBS J., 2007, 274 (13), 3210-3217.
291. Hardingham, G. E., Pro-survival signalling from the NMDA receptor. Biochem. Soc. Trans., 2006, 34 (Pt 5), 936-938.
292. Frodin, M.; Gammeltoft, S., Role and regulation of 90 kDa ribosomal S6 kinase (RSK) in signal transduction. Mol. Cell. Endocrinol., 1999, 151 (1-2), 65-77.
293. Lin, W. Y.; Chang, Y. C.; Lee, H. T.; Huang, C. C., CREB activation in the rapid, intermediate, and delayed ischemic preconditioning against hypoxic-ischemia in neonatal rat. J. Neurochem., 2009, 108 (4), 847-859.
294. Nagakura, A.; Takagi, N.; Takeo, S., Impairment of cerebral cAMP-mediated signal transduction system and of spatial memory function after microsphere embolism in rats. Neuroscience, 2002, 113 (3), 519-528.
295. Mabuchi, T.; Kitagawa, K.; Kuwabara, K.; Takasawa, K.; Ohtsuki, T.; Xia, Z.; Storm, D.; Yanagihara, T.; Hori, M.; Matsumoto, M., Phosphorylation of cAMP response element-binding protein in hippocampal neurons as a protective response after exposure to glutamate in vitro and ischemia in vivo. J. Neurosci., 2001, 21 (23), 9204-9213.
296. Tanaka, K.; Nagata, E.; Suzuki, S.; Dembo, T.; Nogawa, S.; Fukuuchi, Y., Immunohistochemical analysis of cyclic AMP response element binding protein phosphorylation in focal cerebral ischemia in rats. Brain Res., 1999, 818 (2), 520-526.
297. Tanaka, K.; Nogawa, S.; Nagata, E.; Suzuki, S.; Dembo, T.; Kosakai, A.; Fukuuchi, Y., Temporal profile of CREB phosphorylation after focal ischemia in rat brain. Neuroreport, 1999, 10 (11), 2245-2250.
298. Tanaka, K.; Nogawa, S.; Nagata, E.; Ito, D.; Suzuki, S.; Dembo, T.; Kosakai, A.; Fukuuchi, Y., Persistent CREB phosphorylation with protection of hippocampal CA1 pyramidal neurons following temporary occlusion of the middle cerebral artery in the rat. Exp. Neurol., 2000, 161 (2), 462-471.
299. Walton, M.; Sirimanne, E.; Williams, C.; Gluckman, P.; Dragunow, M., The role of the cyclic AMP-responsive element binding protein (CREB) in hypoxic-ischemic brain damage and repair. Brain Res. Mol. Brain Res., 1996, 43 (1-2), 21-29.
300. Mishra, O. P.; Ashraf, Q. M.; Delivoria-Papadopoulos, M., Phosphorylation of cAMP response element binding (CREB) protein during hypoxia in cerebral cortex of newborn piglets and the effect of nitric oxide synthase inhibition. Neuroscience, 2002, 115 (3), 985-991.
301. Chen, M.; Lu, T. J.; Chen, X. J.; Zhou, Y.; Chen, Q.; Feng, X. Y.; Xu, L.; Duan, W. H.; Xiong, Z. Q., Differential roles of NMDA receptor subtypes in ischemic neuronal cell death and ischemic tolerance. Stroke, 2008, 39 (11), 3042-3048.
302. Meller, R.; Minami, M.; Cameron, J. A.; Impey, S.; Chen, D.; Lan, J. Q.; Henshall, D. C.; Simon, R. P., CREB-mediated Bcl-2 protein expression after ischemic preconditioning. J. Cereb. Blood Flow Metab., 2005, 25 (2), 234-246.
303. Terasaki, Y.; Sasaki, T.; Yagita, Y.; Okazaki, S.; Sugiyama, Y.; Oyama, N.; Omura-Matsuoka, E.; Sakoda, S.; Kitagawa, K., Activation of NR2A receptors induces ischemic tolerance through CREB signaling. J. Cereb. Blood Flow Metab., 2010, 30 (8), 1441-1449.
304. Nakajima, T.; Iwabuchi, S.; Miyazaki, H.; Okuma, Y.; Inanami, O.; Kuwabara, M.; Nomura, Y.; Kawahara, K., Relationship between the activation of cyclic AMP responsive element binding protein and ischemic tolerance in the penumbra region of rat cerebral cortex. Neurosci. Lett., 2002, 331 (1), 13-16.
305. Gao, Y.; Gao, G.; Long, C.; Han, S.; Zu, P.; Fang, L.; Li, J., Enhanced phosphorylation of cyclic AMP response element binding protein in the brain of mice following repetitive hypoxic exposure. Biochem. Biophys. Res. Commun., 2006, 340 (2), 661-667.
306. Sugiura, S.; Kitagawa, K.; Omura-Matsuoka, E.; Sasaki, T.; Tanaka, S.; Yagita, Y.; Matsushita, K.; Storm, D. R.; Hori, M., CRE-mediated gene transcription in the peri-infarct area after focal cerebral ischemia in mice. J. Neurosci. Res., 2004, 75 (3), 401-407.
307. Tanaka, K.; Nogawa, S.; Ito, D.; Suzuki, S.; Dembo, T.; Kosakai, A.; Fukuuchi, Y., Phosphorylation of cyclic adenosine monophosphate response element binding protein in oligodendrocytes in the corpus callosum after focal cerebral ischemia in the rat. J. Cereb. Blood Flow Metab., 2001, 21 (10), 1177-1188.
308. Raval, A. P.; Saul, I.; Dave, K. R.; DeFazio, R. A.; Perez-Pinzon, M. A.; Bramlett, H., Pretreatment with a single estradiol-17beta bolus activates cyclic-AMP response element binding protein and protects CA1 neurons against global cerebral ischemia. Neuroscience, 2009, 160 (2), 307-318.
309. Choi, Y. C.; Lee, J. H.; Hong, K. W.; Lee, K. S., 17 Beta-estradiol prevents focal cerebral ischemic damages via activation of Akt and CREB in association with reduced PTEN phosphorylation in rats. Fundam. Clin. Pharmacol., 2004, 18 (5), 547-557.
310. Lee, H. T.; Chang, Y. C.; Tu, Y. F.; Huang, C. C., VEGFA/ VEGFR-2 signaling leading to cAMP response element-binding protein phosphorylation is a shared pathway underlying the protective effect of preconditioning on neurons and endothelial cells. J. Neurosci., 2009, 29 (14), 4356-4368.
311. Lee, H. T.; Chang, Y. C.; Tu, Y. F.; Huang, C. C., CREB activation mediates VEGF-A's protection of neurons and cerebral vascular endothelial cells. J. Neurochem., 2010, 113 (1), 79-91.
312. Zhu, D. Y.; Lau, L.; Liu, S. H.; Wei, J. S.; Lu, Y. M., Activation of cAMP-response-element-binding protein (CREB) after focal cerebral ischemia stimulates neurogenesis in the adult dentate gyrus. Proc. Natl. Acad. Sci. USA, 2004, 101 (25), 9453-9457.
313. Yagita, Y.; Kitagawa, K.; Taguchi, A.; Ohtsuki, T.; Kuwabara, K.; Mabuchi, T.; Matsumoto, M.; Yanagihara, T.; Hori, M., Molecular cloning of a novel member of the HSP110 family of genes, ischemia-responsive protein 94 kDa (irp94), expressed in rat brain after transient forebrain ischemia. J. Neurochem., 1999, 72 (4), 1544-1551.
314. Maroni, P.; Bendinelli, P.; Tiberio, L.; Rovetta, F.; Piccoletti, R.; Schiaffonati, L., In vivo heat-shock response in the brain: signalling pathway and transcription factor activation. Brain Res. Mol. Brain Res., 2003, 119 (1), 90-99.
315. Aoki, M.; Abe, K.; Kawagoe, J.; Nakamura, S.; Kogure, K., The preconditioned hippocampus accelerates HSP70 heat shock gene expression following transient ischemia in the gerbil. Neurosci. Lett., 1993, 155 (1), 7-10.
316. Abe, K.; Kawagoe, J.; Aoki, M.; Kogure, K.; Itoyama, Y., Stress protein inductions after brain ischemia. Cell. Mol. Neurobiol., 1998, 18 (6), 709-719.
317. Zheng, Z.; Kim, J. Y.; Ma, H.; Lee, J. E.; Yenari, M. A., Antiinflammatory effects of the 70 kDa heat shock protein in experimental stroke. J. Cereb. Blood Flow Metab., 2008, 28 (1), 53-63.
318. Matsumori, Y.; Hong, S. M.; Aoyama, K.; Fan, Y.; Kayama, T.; Sheldon, R. A.; Vexler, Z. S.; Ferriero, D. M.; Weinstein, P. R.; Liu, J., Hsp70 overexpression sequesters AIF and reduces neonatal hypoxic/ischemic brain injury. J. Cereb. Blood Flow Metab., 2005, 25 (7), 899-910.
319. Chaitanya, G. V.; Babu, P. P., Multiple apoptogenic proteins are involved in the nuclear translocation of Apoptosis Inducing Factor during transient focal cerebral ischemia in rat. Brain Res., 2008, 1246, 178-190.
320. Tsuchiya, D.; Hong, S.; Matsumori, Y.; Shiina, H.; Kayama, T.; Swanson, R. A.; Dillman, W. H.; Liu, J.; Panter, S. S.; Weinstein, P. R., Overexpression of rat heat shock protein 70 is associated with reduction of early mitochondrial cytochrome C release and subsequent DNA fragmentation after permanent focal ischemia. J. Cereb. Blood Flow Metab., 2003, 23 (6), 718-727.
321. Sun, X. C.; Xian, X. H.; Li, W. B.; Li, L.; Yan, C. Z.; Li, Q. J.; Zhang, M., Activation of p38 MAPK participates in brain ischemic tolerance induced by limb ischemic preconditioning by upregulating HSP 70. Exp. Neurol., 2010, 224 (2), 347-355.
322. Lee, S. H.; Kim, M.; Yoon, B. W.; Kim, Y. J.; Ma, S. J.; Roh, J. K.; Lee, J. S.; Seo, J. S., Targeted hsp70.1 disruption increases infarction volume after focal cerebral ischemia in mice. Stroke, 2001, 32 (12), 2905-2912.
323. Vogt, P. K.; Jiang, H.; Aoki, M., Triple layer control: phosphorylation, acetylation and ubiquitination of FOXO proteins. Cell Cycle, 2005, 4 (7), 908-913.
324. Van Der Heide, L. P.; Hoekman, M. F.; Smidt, M. P., The ins and outs of FoxO shuttling: mechanisms of FoxO translocation and transcriptional regulation. Biochem. J., 2004, 380 (Pt 2), 297-309.
325. Burgering, B. M.; Medema, R. H., Decisions on life and death: FOXO Forkhead transcription factors are in command when PKB/Akt is off duty. J. Leukoc. Biol., 2003, 73 (6), 689-701.
326. Essers, M. A.; Weijzen, S.; de Vries-Smits, A. M.; Saarloos, I.; de Ruiter, N. D.; Bos, J. L.; Burgering, B. M., FOXO transcription factor activation by oxidative stress mediated by the small GTPase Ral and JNK. Embo J., 2004, 23 (24), 4802-4812.
327. Gilley, J.; Coffer, P. J.; Ham, J., FOXO transcription factors directly activate bim gene expression and promote apoptosis in sympathetic neurons. J. Cell. Biol., 2003, 162 (4), 613-622.
328. Gilley, J.; Ham, J., Evidence for increased complexity in the regulation of Bim expression in sympathetic neurons: involvement of novel transcriptional and translational mechanisms. DNA Cell. Biol., 2005, 24 (9), 563-573.
329. Yuan, Z.; Lehtinen, M. K.; Merlo, P.; Villen, J.; Gygi, S.; Bonni, A., Regulation of neuronal cell death by MST1-FOXO1 signaling. J. Biol. Chem., 2009, 284 (17), 11285-11292.
330. Brunet, A.; Sweeney, L. B.; Sturgill, J. F.; Chua, K. F.; Greer, P. L.; Lin, Y.; Tran, H.; Ross, S. E.; Mostoslavsky, R.; Cohen, H. Y.; Hu, L. S.; Cheng, H. L.; Jedrychowski, M. P.; Gygi, S. P.; Sinclair, D. A.; Alt, F. W.; Greenberg, M. E., Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science, 2004, 303 (5666), 2011-2015.
331. Gan, L.; Zheng, W.; Chabot, J. G.; Unterman, T. G.; Quirion, R., Nuclear/cytoplasmic shuttling of the transcription factor FoxO1 is regulated by neurotrophic factors. J. Neurochem., 2005, 93 (5), 1209-1219.
332. Lavery, W.; Hall, V.; Yager, J. C.; Rottgers, A.; Wells, M. C.; Stern, M., Phosphatidylinositol 3-kinase and Akt nonautonomously promote perineurial glial growth in Drosophila peripheral nerves. J. Neurosci., 2007, 27 (2), 279-288.
333. Yang, J. Y.; Zong, C. S.; Xia, W.; Yamaguchi, H.; Ding, Q.; Xie, X.; Lang, J. Y.; Lai, C. C.; Chang, C. J.; Huang, W. C.; Huang, H.; Kuo, H. P.; Lee, D. F.; Li, L. Y.; Lien, H. C.; Cheng, X.; Chang, K. J.; Hsiao, C. D.; Tsai, F. J.; Tsai, C. H.; Sahin, A. A.; Muller, W. J.; Mills, G. B.; Yu, D.; Hortobagyi, G. N.; Hung, M. C., ERK promotes tumorigenesis by inhibiting FOXO3a via MDM2- mediated degradation. Nat. Cell. Biol., 2008, 10 (2), 138-148.
334. Huang, H.; Regan, K. M.; Wang, F.; Wang, D.; Smith, D. I.; van Deursen, J. M.; Tindall, D. J., Skp2 inhibits FOXO1 in tumor suppression through ubiquitin-mediated degradation. Proc. Natl. Acad. Sci. USA, 2005, 102 (5), 1649-1654.
335. Kawano, T.; Morioka, M.; Yano, S.; Hamada, J.; Ushio, Y.; Miyamoto, E.; Fukunaga, K., Decreased akt activity is associated with activation of forkhead transcription factor after transient forebrain ischemia in gerbil hippocampus. J. Cereb. Blood Flow Metab., 2002, 22 (8), 926-934.
336. Shioda, N.; Han, F.; Moriguchi, S.; Fukunaga, K., Constitutively active calcineurin mediates delayed neuronal death through Fasligand expression via activation of NFAT and FKHR transcriptional activities in mouse brain ischemia. J. Neurochem., 2007, 102 (5), 1506-1517.
337. Shioda, N.; Ishigami, T.; Han, F.; Moriguchi, S.; Shibuya, M.; Iwabuchi, Y.; Fukunaga, K., Activation of phosphatidylinositol 3- kinase/protein kinase B pathway by a vanadyl compound mediates its neuroprotective effect in mouse brain ischemia. Neuroscience, 2007, 148 (1), 221-229.
338. Li, D.; Qu, Y.; Mao, M.; Zhang, X.; Li, J.; Ferriero, D.; Mu, D., Involvement of the PTEN-AKT-FOXO3a pathway in neuronal apoptosis in developing rat brain after hypoxia-ischemia. J. Cereb. Blood Flow Metab., 2009, 29 (12), 1903-1913.
339. Ran, R.; Xu, H.; Lu, A.; Bernaudin, M.; Sharp, F. R., Hypoxia preconditioning in the brain. Dev. Neurosci., 2005, 27 (2-4), 87-92.
340. Fan, X.; Heijnen, C. J.; van der Kooij, M. A.; Groenendaal, F.; van Bel, F., The role and regulation of hypoxia-inducible factor-1alpha expression in brain development and neonatal hypoxic-ischemic brain injury. Brain Res. Rev., 2009, 62 (1), 99-108.
341. Chavez, J. C.; LaManna, J. C., Activation of hypoxia-inducible factor-1 in the rat cerebral cortex after transient global ischemia: potential role of insulin-like growth factor-1. J. Neurosci., 2002, 22 (20), 8922-8931.
342. Wang, X.; Deng, J.; Boyle, D. W.; Zhong, J.; Lee, W. H., Potential role of IGF-I in hypoxia tolerance using a rat hypoxic-ischemic model: activation of hypoxia-inducible factor 1alpha. Pediatr. Res., 2004, 55 (3), 385-394.
343. Li, L.; Qu, Y.; Mao, M.; Xiong, Y.; Mu, D., The involvement of phosphoinositid 3-kinase/Akt pathway in the activation of hypoxiainducible factor-1alpha in the developing rat brain after hypoxiaischemia. Brain Res., 2008, 1197, 152-158.
344. Li, L.; Xiong, Y.; Qu, Y.; Mao, M.; Mu, W.; Wang, H.; Mu, D., The requirement of extracellular signal-related protein kinase pathway in the activation of hypoxia inducible factor 1 alpha in the developing rat brain after hypoxia-ischemia. Acta Neuropathol., 2008, 115 (3), 297-303.
345. Shi, Q.; Zhang, P.; Zhang, J.; Chen, X.; Lu, H.; Tian, Y.; Parker, T. L.; Liu, Y., Adenovirus-mediated brain-derived neurotrophic factor expression regulated by hypoxia response element protects brain from injury of transient middle cerebral artery occlusion in mice. Neurosci. Lett., 2009, 465 (3), 220-225.
346. An, H. J.; Maeng, O.; Kang, K. H.; Lee, J. O.; Kim, Y. S.; Paik, S. G.; Lee, H., Activation of Ras up-regulates pro-apoptotic BNIP3 in nitric oxide-induced cell death. J. Biol. Chem., 2006, 281 (45), 33939-33948.
347. Blancher, C.; Moore, J. W.; Robertson, N.; Harris, A. L., Effects of ras and von Hippel-Lindau (VHL) gene mutations on hypoxiainducible factor (HIF)-1alpha, HIF-2alpha, and vascular endothelial growth factor expression and their regulation by the phosphatidylinositol 3'-kinase/Akt signaling pathway. Cancer Res., 2001, 61 (19), 7349-7355.
348. Chen, C.; Pore, N.; Behrooz, A.; Ismail-Beigi, F.; Maity, A., Regulation of glut1 mRNA by hypoxia-inducible factor-1. Interaction between H-ras and hypoxia. J. Biol. Chem., 2001, 276 (12), 9519-9525.
349. Kikuchi, H.; Pino, M. S.; Zeng, M.; Shirasawa, S.; Chung, D. C., Oncogenic KRAS and BRAF differentially regulate hypoxiainducible factor-1alpha and -2alpha in colon cancer. Cancer Res., 2009, 69 (21), 8499-8506.
350. Pedersen, M.; Lofstedt, T.; Sun, J.; Holmquist-Mengelbier, L.; Pahlman, S.; Ronnstrand, L., Stem cell factor induces HIF-1alpha at normoxia in hematopoietic cells. Biochem. Biophys. Res. Commun., 2008, 377 (1), 98-103.
351. Alam, H.; Maizels, E. T.; Park, Y.; Ghaey, S.; Feiger, Z. J.; Chandel, N. S.; Hunzicker-Dunn, M., Follicle-stimulating hormone activation of hypoxia-inducible factor-1 by the phosphatidylinositol 3-kinase/AKT/Ras homolog enriched in brain (Rheb)/mammalian target of rapamycin (mTOR) pathway is necessary for induction of select protein markers of follicular differentiation. J. Biol. Chem., 2004, 279 (19), 19431-19440.
352. Land, S. C.; Tee, A. R., Hypoxia-inducible factor 1alpha is regulated by the mammalian target of rapamycin (mTOR) via an mTOR signaling motif. J. Biol. Chem., 2007, 282 (28), 20534-20543.
353. Scott, C. L.; Walker, D. J.; Cwiklinski, E.; Tait, C.; Tee, A. R.; Land, S. C., Control of HIF-1{alpha} and vascular signaling in fetal lung involves cross talk between mTORC1 and the FGF-10/FGFR2b/Spry2 airway branching periodicity clock. Am. J. Physiol. Lung Cell. Mol. Physiol., 2010, 299 (4), L455-471.
354. Bergeron, M.; Yu, A. Y.; Solway, K. E.; Semenza, G. L.; Sharp, F. R., Induction of hypoxia-inducible factor-1 (HIF-1) and its target genes following focal ischaemia in rat brain. Eur. J. Neurosci., 1999, 11 (12), 4159-4170.
355. Li, Y.; Zhou, C.; Calvert, J. W.; Colohan, A. R.; Zhang, J. H., Multiple effects of hyperbaric oxygen on the expression of HIF-1 alpha and apoptotic genes in a global ischemia-hypotension rat model. Exp. Neurol., 2005, 191 (1), 198-210.
356. Van Hoecke, M.; Prigent-Tessier, A. S.; Garnier, P. E.; Bertrand, N. M.; Filomenko, R.; Bettaieb, A.; Marie, C.; Beley, A. G., Evidence of HIF-1 functional binding activity to caspase-3 promoter after photothrombotic cerebral ischemia. Mol. Cell. Neurosci., 2007, 34 (1), 40-47.
357. Althaus, J.; Bernaudin, M.; Petit, E.; Toutain, J.; Touzani, O.; Rami, A., Expression of the gene encoding the pro-apoptotic BNIP3 protein and stimulation of hypoxia-inducible factor-1alpha (HIF-1alpha) protein following focal cerebral ischemia in rats. Neurochem. Int., 2006, 48 (8), 687-695.
358. Matrone, C.; Pignataro, G.; Molinaro, P.; Irace, C.; Scorziello, A.; Di Renzo, G. F.; Annunziato, L., HIF-1alpha reveals a binding activity to the promoter of iNOS gene after permanent middle cerebral artery occlusion. J. Neurochem., 2004, 90 (2), 368-378.
359. Chen, C.; Ostrowski, R. P.; Zhou, C.; Tang, J.; Zhang, J. H., Suppression of hypoxia-inducible factor-1alpha and its downstream genes reduces acute hyperglycemia-enhanced hemorrhagic transformation in a rat model of cerebral ischemia. J. Neurosci. Res., 2010, 88 (9), 2046-2055.
360. Mojsilovic-Petrovic, J.; Callaghan, D.; Cui, H.; Dean, C.; Stanimirovic, D. B.; Zhang, W., Hypoxia-inducible factor-1 (HIF-1) is involved in the regulation of hypoxia-stimulated expression of monocyte chemoattractant protein-1 (MCP-1/CCL2) and MCP-5 (Ccl12) in astrocytes. J. Neuroinflammation, 2007, 4, 12.
361. Chen, W.; Jadhav, V.; Tang, J.; Zhang, J. H., HIF-1 alpha inhibition ameliorates neonatal brain damage after hypoxicischemic injury. Acta Neurochir. Suppl., 2008, 102, 395-399.
362. Chen, C.; Hu, Q.; Yan, J.; Yang, X.; Shi, X.; Lei, J.; Chen, L.; Huang, H.; Han, J.; Zhang, J. H.; Zhou, C., Early inhibition of HIF-1alpha with small interfering RNA reduces ischemic-reperfused brain injury in rats. Neurobiol. Dis., 2009, 33 (3), 509-517.
363. Helton, R.; Cui, J.; Scheel, J. R.; Ellison, J. A.; Ames, C.; Gibson, C.; Blouw, B.; Ouyang, L.; Dragatsis, I.; Zeitlin, S.; Johnson, R. S.; Lipton, S. A.; Barlow, C., Brain-specific knock-out of hypoxiainducible factor-1alpha reduces rather than increases hypoxicischemic damage. J. Neurosci., 2005, 25 (16), 4099-4107.
364. Tomita, S.; Ueno, M.; Sakamoto, M.; Kitahama, Y.; Ueki, M.; Maekawa, N.; Sakamoto, H.; Gassmann, M.; Kageyama, R.; Ueda, N.; Gonzalez, F. J.; Takahama, Y., Defective brain development in mice lacking the Hif-1alpha gene in neural cells. Mol. Cell. Biol., 2003, 23 (19), 6739-6749.
365. Baranova, O.; Miranda, L. F.; Pichiule, P.; Dragatsis, I.; Johnson, R. S.; Chavez, J. C., Neuron-specific inactivation of the hypoxia inducible factor 1 alpha increases brain injury in a mouse model of transient focal cerebral ischemia. J. Neurosci., 2007, 27 (23), 6320-6332.
366. Sheldon, R. A.; Osredkar, D.; Lee, C. L.; Jiang, X.; Mu, D.; Ferriero, D. M., HIF-1 alpha-deficient mice have increased brain injury after neonatal hypoxia-ischemia. Dev. Neurosci., 2009, 31 (5), 452-458.
367. Bernaudin, M.; Nedelec, A. S.; Divoux, D.; MacKenzie, E. T.; Petit, E.; Schumann-Bard, P., Normobaric hypoxia induces tolerance to focal permanent cerebral ischemia in association with an increased expression of hypoxia-inducible factor-1 and its target genes, erythropoietin and VEGF, in the adult mouse brain. J. Cereb. Blood Flow Metab., 2002, 22 (4), 393-403.
368. Bernaudin, M.; Tang, Y.; Reilly, M.; Petit, E.; Sharp, F. R., Brain genomic response following hypoxia and re-oxygenation in the neonatal rat. Identification of genes that might contribute to hypoxia-induced ischemic tolerance. J. Biol. Chem., 2002, 277 (42), 39728-39738.
369. Jones, N. M.; Bergeron, M., Hypoxic preconditioning induces changes in HIF-1 target genes in neonatal rat brain. J. Cereb. Blood Flow Metab., 2001, 21 (9), 1105-1114.
370. Prass, K.; Scharff, A.; Ruscher, K.; Lowl, D.; Muselmann, C.; Victorov, I.; Kapinya, K.; Dirnagl, U.; Meisel, A., Hypoxiainduced stroke tolerance in the mouse is mediated by erythropoietin. Stroke, 2003, 34 (8), 1981-1986.
371. Ruscher, K.; Freyer, D.; Karsch, M.; Isaev, N.; Megow, D.; Sawitzki, B.; Priller, J.; Dirnagl, U.; Meisel, A., Erythropoietin is a paracrine mediator of ischemic tolerance in the brain: evidence from an in vitro model. J. Neurosci., 2002, 22 (23), 10291-10301.
372. Freret, T.; Valable, S.; Chazalviel, L.; Saulnier, R.; Mackenzie, E. T.; Petit, E.; Bernaudin, M.; Boulouard, M.; Schumann-Bard, P., Delayed administration of deferoxamine reduces brain damage and promotes functional recovery after transient focal cerebral ischemia in the rat. Eur. J. Neurosci., 2006, 23 (7), 1757-1765.
373. Prass, K.; Ruscher, K.; Karsch, M.; Isaev, N.; Megow, D.; Priller, J.; Scharff, A.; Dirnagl, U.; Meisel, A., Desferrioxamine induces delayed tolerance against cerebral ischemia in vivo and in vitro. J. Cereb. Blood Flow Metab., 2002, 22 (5), 520-525.
374. Zhang, B.; Tanaka, J.; Yang, L.; Sakanaka, M.; Hata, R.; Maeda, N.; Mitsuda, N., Protective effect of vitamin E against focal brain ischemia and neuronal death through induction of target genes of hypoxia-inducible factor-1. Neuroscience, 2004, 126 (2), 433-440.
375. Theus, M. H.; Wei, L.; Cui, L.; Francis, K.; Hu, X.; Keogh, C.; Yu, S. P., In vitro hypoxic preconditioning of embryonic stem cells as a strategy of promoting cell survival and functional benefits after transplantation into the ischemic rat brain. Exp. Neurol., 2008, 210 (2), 656-670.
376. Chu, K.; Jung, K. H.; Kim, S. J.; Lee, S. T.; Kim, J.; Park, H. K.; Song, E. C.; Kim, S. U.; Kim, M.; Lee, S. K.; Roh, J. K., Transplantation of human neural stem cells protect against ischemia in a preventive mode via hypoxia-inducible factor-1alpha stabilization in the host brain. Brain Res., 2008, 1207, 182-192.